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Exposure of cells to ultraviolet light results in the formation of DNA
photoproducts, many of which have been linked to skin cancer. The majority of these
photoproducts arise from a photoreaction between two pyrimidines. Irradiation of double
stranded B form DNA under physiological conditions mainly produces adjacent dimers.
Nonadjacent photodimers of both intrastrand and interstrand types are much rarer.
Intrastrand-type nonadjacent dimers form when one or more nucleotides between two
pyrimidines become extrahelical owing to the formation of single strand DNA or a
slipped structure.

This allows the two pyrimidines to photodimerize in a colinear

arrangement, as if the intervening sequence was not present.
Enzyme digestion, chemical hydrolysis, high performance liquid chromatography
(HPLC) coupled with mass spectrometry (MS) have been been powerful tools for
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identification and characterization of DNA photoproducts. Using these tools we
discovered an unusual nonadjacent thymine dimer product formed between two T’s with
5 nucleotides apart in a single-standed 14-mer ODN sequence. This novel and
unexpected photoproduct arises from an interstrand-type reaction due to an unusual
higher order folded DNA structure.
This finding led us to investigate the photochemistry of biologically relevant Gquadruplexes, which have high biological relevance in telomers. We studied the
consequences of UV irradiation of G-quadruplex structures of a 22-mer telomeric
sequence by utilizing site-specifically modified DNA, HPLC, CD, and nuclease P1 (NP1)
coupled with MS. A large number of specific anti thymine dimers were formed between
two T’s located in different loops of the telomeric G-quadruplexes. If these unique
nonadjacent anti thymine dimer photoproducts also form in vivo, they may constitute a
previously unrecognized type of DNA photodamage that interferes with telomere
replication and present a unique challenge to DNA repair.
We also describe the characterization of a new photoproduct

m

CA*, whose

deamination product has the same structure as the well-known TA* photoproduct. The
structure proof was done with a combination of NP1 digestion, HPLC correlation, and
MSn techniques.
A second part of the thesis deals with a DNA-binding protein.

Human

apurinic/apyrimidinic endonuclease 1 (hApe1) contributes to DNA repair by cleaving
apurinic/apyrimidinic sites of damaged DNA. Additionally, hApe1 is a bifunctional
protein functioning as a redox factor that simulates DNA binding activity of several
transcription factors that are involved in cancer promotion and progression including AP-
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1, P53 and others. The underlying mechanism of its redox activity, however, is poorly
understood. One proposed mechanism is the disulfide exchange between hApe1 and the
transcription factors. It’s also hypothesized that hApe1 undergoes conformational
changes that allows it to interact with the transcription factors. A quinone derivative
E3330,

(2E)-3-[5-(2,3-dimethoxy-o-methyl-1,4-benzoquinoyl)]-2-nonyl-2-propenoic

acid, is a specific redox-activity inhibitor for hApe1. We used MS-based methods to
probe the structure, dynamics, and interactions of HApe1 with ligands. We used amide
hydrogen/deuterium exchange (HDX) and N-ethylmaleimide (NEM) labeling coupled
MS analysis to probe the interaction of hApe1 and E3330. Our study suggests there is a
minor amount of a locally unfolded form existing in equilibrium with the major folded
form of hAp1. This locally unfolded form interacts with E3330 and is stabilized, allowing
formation of disulfide bonds (C65-C93, C65-C99, C93-C99) in the redox active domain.
A previous cell-based assay suggests that C65 is essential and thatC93 and C99 are also
involved in the redox activity of hApe1. Taken together, we propose that the locally
unfolded form is responsible for the redox function of hApe1 via a thiol/disulfide
mechanism.

iv

ACKNOWLEDGMENTS
It is my pleasure to thank those who made this thesis possible.
I would like to express my sincere thanks to my two wonderful advisors Prof.
Michael L. Gross and Prof. John-Stephen A. Taylor. It is such an honor for me to work
with both of them over the past five years at Washington University. I owe my deepest
gratitude to them with their enthusiastic guidance, sound advice, perceptive criticisms,
and constant encouragement. I thank my advisors for providing me the unique
opportunity to work on challenging projects and giving me ample room to explore
research possibilities and pursue ideas on my own. I particularly thank them for their
critical push and inspiration during the tough time of my research projects, without which
I would not have gone this far.
I owe my deepest gratitude to Andre d’Avignon, Henry W. Rohrs, Bich Vu, for
their fantastic friendship and unconditional help. I thank Ilan Geerlof-Vidaysky and
Maida Geerlof-Vidaysky for adopting me as their family member, which allowed me to
feel like home in Saint Louis. Thanks to Drs. Ed Hiss and Alfred Hortmann for treating
me as a friend.
I would like to acknowledge gratefully Bich Vu, Richard Huang, Hao Zhang,
Weidong Cui, Don Rempel, Huafeng Fang, Ajay Kshetry and Jeff Kao for their
contribution and help during my thesis research. I also thank all my colleagues in the
Gross group especially, Justin Sperry, Adam Brustkern, Jiawei Chen, Lisa Jones, Joyce
Neff, Daryl Gibln, James Walters and those of the Taylor group especially, Xuan (Adele)
Yue, Dan Gu, Jianfeng Cai, Gang Sheng, Zhenghui Wang, Ziyan Zhang and Vincent

v

Cannistraro. I also thank Jianzhong Wen from the Blankenship lab. Their friendship and
professional collaboration means a great deal to me.
My special thanks go to our collaborator Dr. Millie M. Georgiadis with Sarah
Delaplane from department of Biochemistry and Molecular Biology, Indiana University
School of Medicine, Indianapolis, Indiana.
I wish to thank my Dissertation Advisory and Examination Committee members,
Dr. Robert E. Blankenship, Dr. Peter M. Burgers, Dr. Ron Bose, Dr. Jacob Schaefer, and
Dr. Joshua A. Maurer for their reading my thesis and proving valuable advice.
This thesis is dedicated to my parents, sister and my boyfriend Hao Zhang. I can
never overstate my gratitude to them for their endless love, encouragement and support.
They made me who I am today. My parents are my true heroes always and forever.
This research was supported by NIH Grants CA40463, CA114571 and by the by
the Washington University NIH Mass Spectrometry Resource (Grant No. P41
RR000954) and Washington University NMR facility (Grant No. RR1571501).

vi

TABLE OF CONTENTS
ABSTRACT OF THE DISSERTATION ........................................................................... ii
ACKNOWLEDGMENTS .................................................................................................. v
TABLE OF CONTENTS .................................................................................................. vii
LIST OF TABLES .............................................................................................................. x
LIST OF FIGURES .......................................................................................................... xii
LIST OF SCHEMES...................................................................................................... xviii

Chapter 1
Introduction

Part 1: Discovery and Identification of New DNA Photoproducts .................................... 2
Part 2: Investigation of the Redox Mechanism of HApe1 Protein ..................................... 4
References ........................................................................................................................... 5

Chapter 2
Structure Determination of an Interstrand-Type Cis-Anti Cyclobutane Thymine
Dimer Produced in High Yield by UVB Light in an Oligodeoxynucleotide at Acidic
pH

Abstract ............................................................................................................................. 14
Introduction ....................................................................................................................... 15
Material and Methods ....................................................................................................... 17

vii

Results and Discussion ..................................................................................................... 23
Conclusions ....................................................................................................................... 35
Acknowledgment .............................................................................................................. 36
References ......................................................................................................................... 37

Chapter 3
Photocrosslinking of Human Telomeric G-quadruplex Loops by Anti Cyclobutane
Thymine Dimer Formation

Abstract ............................................................................................................................. 70
Introduction ....................................................................................................................... 71
Material and Methods ....................................................................................................... 72
Results ............................................................................................................................... 75
Conclusion ........................................................................................................................ 83
Acknowledgment .............................................................................................................. 84
References ......................................................................................................................... 85

Chapter 4
mCA*: A New Photoproduct of 5' -Methylcytosine and Adenine Characterized by
HPLC and Mass Spectrometry

Abstract ........................................................................................................................... 107
Introduction ..................................................................................................................... 108
Materials and Methods.................................................................................................... 109

viii

Results and Discussion ................................................................................................... 111
Conclusion ...................................................................................................................... 115
Acknowledgments........................................................................................................... 116
References ....................................................................................................................... 117

Chapter 5
A Mass Spectrometric Investigation of the Interaction of hApe1 with the Redox
Activity Inhibitor, E3330

Abstract ........................................................................................................................... 134
Introduction ..................................................................................................................... 136
Material and Methods ..................................................................................................... 138
Results ............................................................................................................................. 144
Discussion ....................................................................................................................... 154
Conclusions ..................................................................................................................... 157
Acknowledgment ............................................................................................................ 157
References ....................................................................................................................... 159

ix

LIST OF TABLES
Chapter 2
Structure Determination of an Interstrand-Type Cis-Anti Cyclobutane Thymine
Dimer Produced in High Yield by UVB Light in an Oligodeoxynucleotide at Acidic
pH
Table 2.1. Proton and 31P chemical shifts of the parent ODN and photoproduct I in D2O
at 25 oC.............................................................................................................................. 44
Table 2.2. Photoproduct yields for mutant sequences of d(GTATCATGAGGTGC).
ODNs (50 µM) were irradiated at pH 4.8 for 2.5 h at 0 ºCa,b. .......................................... 45
Chapter 3
Photocrosslinking of Human Telomeric G-quadruplex Loops by Anti Cyclobutane
Thymine Dimer Formation
Table 3.1. Stereochemistry, base composition, and loop assignment of the NP1 digestion
products of UV-irradiated Tel22 shown in Figure 3.5...................................................... 90
Table 3.2. Stereochemistry, composition, and loop assignment of the NP1 digestion
products of Tel22-Un (n=1, 2, 3) in Figure 3.5 C, D, and E. ............................................ 91

x

Chapter 4
mCA*: A New Photoproduct of 5' -Methylcytosine and Adenine Characterized by
HPLC and Mass Spectrometry
Table 4.1. Identification of UVB induced photoproducts of d(GTATmCATGAGGTGC)
at pH 7.6. ......................................................................................................................... 123

xi

LIST OF FIGURES
Chapter 1
Introduction
Figure 1.1. Structures of the DNA photoproducts. .......................................................... 10
Figure 1.2. The two major functions of hApe1: Redox regulatory/signaling and DNA
repair. ................................................................................................................................ 11
Chapter 2
Structure Determination of an Interstrand-Type Cis-Anti Cyclobutane Thymine
Dimer Produced in High Yield by UVB Light in an Oligodeoxynucleotide at Acidic
pH
Figure 2.1. Photochemistry of DNA. ............................................................................... 46
Figure 2.2. HPLC analysis of photoproduct formation and reversal ............................... 47
Figure 2.3. NMR spectra of photoproduct I and the parent ODN. .................................. 49
Figure 2.4. NOESY subspectra of the parent ODN. ........................................................ 50
Figure 2.5. NOESY subspectra for photoproduct I.......................................................... 51
Figure 2.6. 1H-31P HSQC and TOCSY subspectra of the parent ODN. ........................... 52
Figure 2.7. 1H-31P HSQC and TOCSY subspectra of photoproduct I. ............................ 53
Figure 2.8. Exonuclease-coupled MS ladder sequencing of the parent ODN. ................ 54

xii

Figure 2.9. Exonuclease-coupled MS ladder sequencing of photoproduct I. .................. 55
Figure 2.10. BIMP sequencing of photoproduct I. .......................................................... 56
Figure 2.11. Mass spectrometry analysis of the NP1 digestion product of photoproduct I
........................................................................................................................................... 57
Figure 2.12. Structure correlation of the cyclobutane thymine dimer ............................. 58
Figure 2.13. ESI-MS/MS characterization of the cyclobutane thymine dimers .............. 59
Figure 2.14. Section of NOESY spectra of photoproduct I at 25 ºC. .............................. 60
Figure 2.15. Structure and stereochemistry of the cis-anti stereoisomers of the T2[c,a]T7
product .............................................................................................................................. 61
Figure 2.16. Photoreversal of UVB irradiation products to the parent ODN .................. 62
Figure 2.17. Mass spectrometry analysis of NP1 digestion product of minor I and minor
II. ....................................................................................................................................... 63
Figure 2.18. BIMP digestion (3'→5') coupled MALDI sequencing of minor photoproduct
II. ....................................................................................................................................... 64
Figure 2.19. Thymine dimer stereochemistry of minor photoproducts I and II by
chemical correlation .......................................................................................................... 65
Figure 2.20. ESI-MS/MS characterization of the cyclobutane thymine dimers. ............. 66
Figure 2.21. Formation and identification of the T2[c,a]T7 product in the mut6 sequence
........................................................................................................................................... 67

xiii

Chapter 3
Photocrosslinking of Human Telomeric G-quadruplex Loops by Anti Cyclobutane
Thymine Dimer Formation
Figure 3.1. Known basket, hybrid-1, and hybrid-2 triple quartet forms of human
telomeric DNA that could be adopted by Tel22 ............................................................... 92
Figure 3.2. Telomeric substrates and cyclobutane pyrimidine dimer photoproducts ...... 93
Figure 3.3. CD spectra of 50 µM Tel22 G-quadruplexes in 10mM Tris-HCl (pH 7.5) at 4
ºC....................................................................................................................................... 94
Figure 3.4. Analysis of UVB irradiated telomeric quadruplexes..................................... 95
Figure 3.5. NP1-coupled HPLC assay of Tel22 and the U-substituted sequences after 2.5
h UVB irradiation at pH 7.5.............................................................................................. 97
Figure 3.6. ESI-MS/MS and HF/pyridine hydrolysis assay of HPLC peak 3. ................ 98
Figure 3.7. ESI-MS/MS of (A) HPLC peak n-1 (n = 1, 2, and 3), pd[T=UA] and (B)
HPLC peak n -2 (n = 1, 2, and 3), pd[T=AG] corresponding to the TA* photoproduct. . 99
Figure 3.8. ESI-MS, ESI-MS/MS, and HF/pyridine hydrolysis-coupled HPLC assay of
HPLC peak 11 ................................................................................................................. 100
Figure 3.9. ESI-MS, ESI-MS/MS, and HF/pyridine hydrolysis-coupled HPLC assay of
HPLC peak 9. .................................................................................................................. 101
Figure 3.10. ESI-MS and ESI-MS/MS of HPLC peak 1-6. ........................................... 102

xiv

Figure 3.11. ESI-MS and ESI-MS/MS of HPLC peak 3-6. ........................................... 103
Figure 3.12. Photodimer sites mapped onto chair and Form III G-quadruplex forms of
Tel22 and onto triplex intermediates possibly involved in equilibrating between these and
other structures. ............................................................................................................... 104
Figure 3.13. NP1-coupled HPLC assay of UV-irradiated Tel19, Tel 22-A3, and Tel26.
......................................................................................................................................... 105

Chapter 4
mCA*: A New Photoproduct of 5' -Methylcytosine and Adenine Characterized by
HPLC and Mass Spectrometry
Figure 4.1. RP-HPLC of UVB-induced photoproducts of d(GTATmCATGAGGTGC) at
pH 7.6 (upper panel) and of corresponding deamination products (lower panel) with A)
302 nm light and B) 312 nm light. .................................................................................. 124
Figure 4.2. Product-ion spectra of the trinucleotides of NP1 digested photoproducts PP1
(A) and PP1* (B), indicating a mC<>A and T<>A photoproduct, respectively. ............ 125
Figure 4.3. Product-ion spectra of the trinuclteotides of NP1 digested photoproducts PP2
(A) and PP2* (B), indicating a T<>mC and T<>T photoproduct, respectively. ............. 126
Figure 4.4. Product-ion spectrum of the trinucleotide of NP1 digested photoproduct PP3,
indicating a T<>mC photoproduct. .................................................................................. 127
Figure 4.5. Product-ion spectrum of the trimucleotide of NP1 digested photoproduct PP4,
indicating a T<>mC photoproduct. .................................................................................. 128

xv

Figure 4.6. RP-HPLC assay of A) ~ 5 nmol UVC irradiation mixture of
d(GTATTATGAGGTGC), B) ~ 360 pmol of deamination product of HPLC fraction of
d(GTATmCATGAGGTGC), and C) a coinjected sample of A and B. ......................... 129
Figure 4.7.

NP1 coupled ESI- MS2 and MS3 assays of

m

C<>A photoproduct of

d(GTATmCATGAGGTGC) following deamination to T<>A (A and B, respectively), and
TA* photoproduct of T5A6 of d(GTATTATGAGGTGC) (C and D, respectively). ..... 130

Chapter 5
A Mass Spectrometric Investigation of the Interaction of hApe1 with the Redox
Activity Inhibitor, E3330
Figure 5.1. X-ray crystal structure (PDB: 1BIX) of hApe1 with seven cysteines shown
as sticks (red). ................................................................................................................. 170
Figure 5.2. Amino acid sequence of the ApeΔ40 (cysteine residues are underscored). 171
Figure 5.3. HDX kinetics of ApeΔ40 alone and in the presence of E3330 ................... 172
Figure 5.5. ESImass spectrum of ApeΔ40 and E3330 with 50% ACN with 0.1% FA at
10 µL/min. ...................................................................................................................... 174
Figure 5.6. NanoESI mass spectra of ApeΔ40 without (A) and with E3330 (B). ......... 175
Figure 5.7. ESI mass spectra of ApeΔ40 after incubation without and with E3330 in the
presence of NEM for 30 min (left panel) and 6 h (right panel). ..................................... 176
Figure 5.8. MS/MS spectra that show C99 and C138 were modified by NEM. ........... 177

xvi

Figure 5.9. Kinetics of Ape and NEM reaction in (A) Ape Δ40/NEM sample and (B)
ApeΔ40/E3330/NEM sample. ........................................................................................ 178
Figure 5.10. ESI mass spectra of ApeΔ40 mutant C65A without and with incubation
with E3330 in the presence of NEM for 12 h. ................................................................ 180
Figure 5.11. HDX kinetics results of “ApeΔ40 + 2 NEM”, “ApeΔ40 + 3 NEM” and
“ApeΔ40 + 7 NEM”........................................................................................................ 181
Figure 5.12. Normalized percentages of disulfide linkages in the ApeΔ40 control and
ApeΔ40/E3330 samples .................................................................................................. 182
Figure 5.13. MS/MS spectrum that shows disulfide bond formation between C65 and
C93. ................................................................................................................................. 183
Figure 5.14. MS/MS spectrum that shows disulfide bond formation between C65 and
C99 .................................................................................................................................. 184
Figure 5.15. Product-ion spectrum (MS/MS) showing disulfide bond formation between
C93 and C99. .................................................................................................................. 185
Figure 5.16. MS/MS spectrum that shows disulfide bond formation between C65 and
C138 ................................................................................................................................ 186
Figure 5.17. MS/MS spectrum that shows disulfide bond formation between C93 and
C138. ............................................................................................................................... 187
Figure 5.18. ESI mass spectrum of FL-Ape with E3330 in the presence of NEM for 12 h
......................................................................................................................................... 188

xvii

LIST OF SCHEMES

Chapter 1
Introduction
Scheme 1.1. Intra- (A) and inter- (B) strand-type photoreactions, both of which lead to
nonadjacent photoproducts, except when n = 0 for A, which results in an adjacent
photoproduct. .................................................................................................................... 12

Chapter 2
Structure Determination of an Interstrand-Type Cis-Anti Cyclobutane Thymine
Dimer Produced in High Yield by UVB Light in an Oligodeoxynucleotide at Acidic
pH
Scheme 2.1. Proposed enzymatic cleavage pathway by SVP for the T2[c,a]T7
photoproducts of the original sequence and mut6 (A6G). ................................................ 68

Chapter 4
mCA*: A New Photoproduct of 5' -Methylcytosine and Adenine Characterized by
HPLC and Mass Spectrometry
Scheme 4.1. Known photoproducts that could originate from the designed sequence. 131

xviii

Scheme 4.2. Proposed structure of the

m

C<>A photoproduct and its mechanism of

formation and deamination. ............................................................................................ 132

Chapter 5
A Mass Spectrometric Investigation of the Interaction of hApe1 with the Redox
Activity Inhibitor, E3330
Scheme 5.1. Proposed system equations explaining the NEM labeling of ApeΔ40 in the
presence of E3330. .......................................................................................................... 189

xix

Chapter 1

Introduction

1

This thesis has two parts: discovery and identification of New DNA
photoproducts (part 1) and investigation of the redox mechanism of human
apurinic/apyrimidinic endonuclease 1 (hApe1) protein (part 2). In this introductory
chapter, we will describe the types of DNA photodamage and summarize three new
classes of photoproducts that we discovered by a combination of several analytical
methods. In the second part, we investigated an important interaction of hApe1 protein
with an inhibitor E3330, (2E)-3-[5-(2,3-dimethoxy-o-methyl-1,4-benzoquinoyl)]-2nonyl-2-propenoic acid, by mass spectrometry (MS)-based methods.

Part 1: Discovery
Photoproducts

and

Identification

of

New

DNA

UVB overlaps the upper end of the DNA absorption spectra and is the range
mainly responsible for skin cancer through direct photochemical damage to DNA. Up to
now, the most prevalent UV photoproducts induced by UVB or UVC irradiation are
found at adjacent pyrimidine sites, giving cyclobutane dimers, (6-4), and their Dewar
valence isomers (Figure 1.1) (1-5). Other rare UV photoproducts, including the spore
photoproduct, TA*, A=A, and AA* are also well known (Figure 1.1) (6-16). If not
repaired, the photoproducts may interfere with DNA replication or transcription. If
bypassed by a DNA polymerase, they may lead to mutations by inserting an incorrect
complementary base in the next replication cycle.
Nonadjacent photodimers of both intrastrand and interstrand types are much rarer.
Intrastrand-type nonadjacent dimers form when one or more nucleotides between two
pyrimidines become extrahelical, owing to the formation of single strand DNA or a
slipped structure, thereby allowing the two pyrimidines to photodimerize in a colinear
arrangement, as if the intervening sequence were not present (Scheme 1.1). Because
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nonadjacent dimer formation effectively shortens the DNA template, this type of
photoproduct has been implicated in the formation of UV-induced deletion mutations
(17). The formation of this interstrand photoproduct also suggests that such
photoproducts might also form in biologically important, higher order DNA structures
including between the loops of G-quartet structures in telomeres and promoters and
between strands in i-motif structures (18, 19).
In part I of the thesis, we describe the discovery of new nonadjacent and adjacent
DNA photoproducts by using a combined approach of enzymatic and/or chemical
degradation, HPLC, NMR, and mass spectrometry.
In chapter 2, we report on an unusual nonadjacent photoproduct that is formed in
high yield when irradiating the single-stranded ODN d(GTATCATGAGGTGC) with
UVB light at acidic pH(20). We obtained evidence from HPLC comparisons, exo- and
endo-nuclease coupled MS, and from NMR that this photoproduct is an interstrand-type
(see scheme 1.1 for definition of “interstrand-type”) of nonadjacent cis-anti cyclobutane
thymine dimer formed between T2 and T7. This discovery suggests that some folded
structure of the short single-stranded oligomer must exist and allow the photocrosslink to
occur. This hypothesis led to an extensive study of the photochemistry of human
telomeric G-quadruplex structures (Chapter 3).
In chapter 3, we describe the discovery of inter-loop photocrosslinking of a 22mer human telomeric sequence d[AGGG(TTAGGG)3](21). The product forms via a cisanti thymine nonadjacent dimer. Owing to the presence of multiple reactant thymines, it
is difficult to locate the sites of nonadjacent thymine dimerization. We implemented an
efficient solution for accurately locating the thymine dimers by replacing specific
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thymines with the photoequivalent uracils, followed by enzyme-coupled HPLC and
tandem MS analysis.
In chapter 4, we report a new photoproduct mCA* between mC and A(22). We
show how comparison of HPLC properties with those of authentic materials and of
tandem MS can be used to determine the deamination product of the mC<>A, T<>A, has
the same stereochemistry as the known photoproduct of TA*.

Part 2: Investigation of the Redox Mechanism of HApe1
Protein
HApe1 is a multi-functional protein (Figure 1.2) (23-29). It repairs DNA by
cleaving apurinic/apyrimidinic sites of damaged DNA. Additionally, hApe1 functions as
a redox factor to simulate DNA binding activity of several transcription factors (e.g., AP1, P53) that are involved in cancer promotion and progression. However, the underlying
mechanism of its redox activity is poorly understood. A quinone derivative E3330
inhibits the redox ability of hApe1 (30-33).
In chapter 5, we report our probe of the interaction between Ape'40, a truncated
form lacking the N-terminal 40 residues of hApe1, and its redox-activity inhibitor E3330
with amide hydrogen/deuterium (H/D) exchange and N-ethylmaleimide labeling. Most
of the analysis is with mass spectrometry, providing an insight on the redox mechanism
of hApe1. On the basis of our results, we proposed that a locally unfolded form exists,
which interacts with E3330 and exists in equilibrium with the folded form. Interaction
with E3330 allows disulfide bonds to form in the redox domain of hApe1. The locally
unfolded form is thereby proposed to be the potential redox-active form.
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Scheme 1.1. Intra- (A) and inter- (B) strand-type photoreactions, both of which lead to
nonadjacent photoproducts, except when n = 0 for A, which results in an adjacent
photoproduct.
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Chapter 2

Structure Determination of an InterstrandType Cis-Anti Cyclobutane Thymine Dimer
Produced in High Yield by UVB Light in an
Oligodeoxynucleotide at Acidic pH
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Abstract
The unusual structural forms of telomere DNA, which protect the ends of UVB
irradiation of DNA produces photodimers in adjacent DNA bases and on rare occasions
in nonadjacent bases. UVB irradiation (312 nm) of d(GTATCATGAGGTGC) gave rise
to an unknown DNA photoproduct in approximately 40% yield at acidic pH of about 5.
This product has a much shorter retention time in reverse phase HPLC compared to
known dipyrimidine photoproducts of this sequence. A large upfield shift of two thymine
H6 NMR signals and photoreversion to the parent ODN upon irradiation with 254 nm
light indicates that the photoproduct is a cyclobutane thymine dimer. Exonucleasecoupled MS assay establishes that the photodimer forms between T2 and T7, which was
confirmed by tandem mass spectrometric MS/MS identification of the endonuclease P1
digestion product pd(T2[A3])=pd(T7[G8]). Acidic hydrolysis of the photoproduct gave a
product with the same retention time on reverse phase HPLC and the same MS/MS
fragmentation pattern as authentic Thy[c,a]Thy. 2D NOE NMR data are consistent with a
cis-anti cyclobutane dimer between the 3'-sides of T2 and T7 in anti glycosyl
conformations that had to have arisen from an interstand type reaction. In addition to pH
dependency, the photoproduct yield is highly sequence specific and concentration
dependent, indicating that it results from a higher order folded structure. The efficient
formation of this interstrand-type photoproduct suggests the existence of a new type of
folding motif and the possibility that this type of photoproduct might also form in other
folded structures, such as G-quadruplexes and i-motif structures which can be now
studied by the methods described.

14

Introduction
Exposure of cells to ultraviolet light results in the formation of DNA
photoproducts, many of which have been linked to skin cancer (1-4). The majority of
these photoproducts arise from a photoreaction between two pyrimidines, the structure
and stereochemistry of which depend on the conformation of the two bases at the time of
irradiation. Irradiation of double stranded B form DNA under physiological conditions
mainly produces cis-syn cyclobutane pyridine dimers (CPDs), pyrimidine (6-4)
pyrimidone photoproducts, and their Dewar valence isomers (Figure 2.1A) (5-9). Minor
amounts of the trans-syn-I cyclobutane dimer have been detected in irradiated samples of
native double stranded DNA and presumably form from single-stranded sections of DNA
in which the thymine base has rotated into a syn-glycosyl conformation prior to
photodimerization. A form DNA, on the other hand, appears to suppress these
photoproducts and instead favors formation of the spore photoproduct (10, 11).
Nonadjacent photodimers of both intrastrand and interstrand types are much rarer.
Intrastrand-type nonadjacent dimers form when one or more nucleotides between two
pyrimidines become extrahelical, due to the formation of single strand DNA or a slipped
structure, thereby allowing the two pyrimidines to photodimerize in a colinear
arrangement, as if the intervening sequence was not present (Figure 2.1B). Because
nonadjacent dimer formation effectively shortens the DNA template, this type of
photoproduct has been implicated in the formation of UV-induced deletion mutations
(12). Nonadjacent thymine dimers having a predominantly cis-syn configuration form in
d(GT)n upon germicidal lamp irradiation (λmax 254 nm) (12) and near-ultraviolet
irradiation (λmax 310 nm) (13). A nonadjacent cis-syn cyclobutane dimer between the two
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Ts of TCT was subsequently prepared in good yield by triplet-sensitized irradiation of a
bulged loop duplex DNA structure formed between the 13-mer d(GAGTATCTATGAG)
and the 12-mer d(CTCATAATACTC) (14).
Interstrand-type DNA photoproducts arise from reactions between bases on
opposing strands of duplex DNA in a parallel or antiparallel orientation (Figure 2.1C)
and have not been detected under native, aqueous conditions. An early study showed that
d(GT)n•(CA)n could be photo-cross-linked in ethanolic solutions or in aqueous solutions
containing a high concentration of manganese (15). More recently, UVC irradiation of
freeze-dried and alcoholic solutions of calf thymus DNA have been reported to give
significant amounts of interstrand photoproducts (11). Enzymatic degradation of DNA
irradiated under these conditions revealed the formation of nonadjacent spore
photoproduct, as well as nonadjacent cis-syn, cis-anti, and trans-anti cyclobutane
pyrimidine dimers. Nonadjacent photoproducts were distinguished from adjacent
photoproducts by the absence of an internucleotide phosphate linkage following
enzymatic digestion. The formation of the nonadjacent photoproducts was attributed to
interstrand-type reactions between the bases (Figure 2.1B, bottom row), but some of
these products could have arisen from intrastrand-type reactions (Figure 2.1B, top row).
The method used, however, does not allow distinction between inter- and intrastrand
nonadjacent photodimers.
In the course of irradiating d(GTATCATGAGGTGC) with UVB light to prepare
a site-specific cis-syn TC cyclobutane dimer photoproduct for study, we discovered a
new DNA photoproduct that was produced in unusually high yield at acidic pH. In this
chapter, we describe physical, enzymatic, MS, and NMR evidence that this photoproduct
is an interstrand-type nonadjacent cis-anti cyclobutane thymine dimer product formed
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between T2 and T7. This novel and unexpected photoproduct can be explained to arise
from an interstrand-type reaction due to an unusual higher order folded DNA structure.
This is the first interstrand-type nonadjacent photoproduct to be characterized in DNA
and the first to be produced efficiently in aqueous solution and points to the existence of
a new type of DNA folding motif. The facile formation of this interstrand photoproduct
also suggests that such a photoproduct may form in other folded structures, such as Gquadruplexes in telomeres and promoters, and i-motif structures (16, 17), which could
now be studied by the methods described herein.

Material and Methods
Materials
Oligodeoxynucleotides were purchased from Integrated DNA Technologies, Inc.
(IDT) (Coralville, Iowa). Snake venom phosphodiesterase (SVP) from Crotalus
adamanteus was provided by Worthington Biochemical Corp. (Lakewood, NJ). Bovine
spleen phosphodiesterase (BSP), nuclease P1 (NP1) from Penicillium citrinum, thymine,
and 70% hydrogen fluoride in pyridine were all from Sigma (St. Louis, MO). Ammonium
citrate and 3-hydroxypicolinic acid (3-HPA) for use as MALDI matrices were purchased
from Fluka (Milwaukee, WI). 100% D2O (99.96% atom %D) for NMR was from Aldrich
(St. Louis, MO). Milli-Q (18.2 mΩ/cm) water was obtained from a Milli-Q water
purification system (Millipore Corporation, Billerica, MA). HPLC solvents were from
Fisher (Fair Lawn, NJ).
Instrumentation
HPLC separation and analysis were carried out on System Gold HPLC
BioEssential with a binary gradient 125 pump and a diode array 168 detector (Beckman
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Coulter, Inc., Fullerton, CA). An X-Bridge column (C18, 4.6 × 75 mm, 2.5 µm, 135 Å)
from Waters Corporation (Milford, MA) was used for reverse-phase HPLC. UVB (280320 nm) irradiation was carried out with two Spectroline XX-15B UV 15W tubes (312
nm) with peak UV intensity of 1150 µW/cm2 at 25 cm and Longlife filter glass from
Spectronics Corporation (Westbury, NY). UVC irradiation was carried out with a model
UVG-254 mineralight lamp (254 nm, Ultra-Violet Products, Inc., San Gabriel, CA).
MALDI mass spectra were collected on an Applied Biosystems 4700 tandem time-offlight mass spectrometer (Applied Biosystems, Foster City, CA), and ESI mass spectra
were collected on an Thermo Finnigan LCQ classic mass spectrometer (Thermo Fisher
Scientific, Inc., Waltham, MA). NMR spectra were recorded with Varian Inova-600
(Varian Assoc., Palo Alto, CA) spectrometers, and the data were processed off-line with
Varian VNMR software.
UV Irradiation of Oligodeoxynucleotides (ODNs)
ODNs

from

IDT

were

used

without

further

purification.

ODN

d(GTATTATGAGGTGC) in Milli-Q water and d(GTATCATGAGGTGC) in 10 mM
acetate buffer, pH 4.8, (50 µM) were purged with nitrogen for 5 min and placed in
separate polyethylene Ziplock bags filled with nitrogen. The bags were placed on ice and
irradiated for 2-2.5 h at a distance of about 1 cm from a UVB lamp. For the pH study the
following buffers were used: 10 mM sodium citrate buffer (pH 3.6), sodium acetate
buffer (pH 4.6, 4.8, 5.0, 5.2, 5.4, 5.6), 10 mM sodium 2-(N-morpholino)ethanesulfonate
(MES) buffer (pH 5.7), 10 mM potassium phosphate buffer (pH 7.0), and 10 mM
tris(hydroxymethyl)aminomethane-HCl (pH 7.8).
Reverse Phase HPLC Analysis and Purification of Products
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Four gradients were used, all at a flow rate of 1 mL/min. Method A: 50 min 020% solvent B in solvent A (solvent A: 50 mM ammonium acetate, pH 6.8; Solvent B:
50% acetonitrile in 50 mM ammonium acetate, pH 6.8); method B: 50 min 0-15% solvent
B in solvent A (solvent A: 5% acetonitrile in 50 mM triethylammonium acetate, pH 7.0;
solvent B: 50% acetonitrile in 50 mM triethylammonium acetate, pH 7.0); method C: 50
min 0-20% solvent B in solvent A (solvent A: 50 mM triethylammonium acetate, pH 7.0;
solvent B: 50% acetonitrile in 50 mM triethylammonium acetate, pH 7.0); method D:
100% Milli-Q water. The effluent was monitored at 260 nm for methods A-C, and 205
nm for method D.
Thermal and Hydrolytic Stability
Assay The thermal and hydrolytic stability of the photoproducts were determined
with 100 µL of 50 µM UVB irradiated ODN in 10 mM sodium acetate buffer (pH = 4.8)
in an Eppendorf microcentrifuge tube in a 37 ºC water bath.
Exonuclease-Coupled MS Sequencing
The ODN (150 pmol) was incubated with 0.01 units of SVP in 8 µL of 10 mM
ammonium citrate (pH at 9.4) at 37 ºC or with 0.01 units of BSP in 8 µL of Milli-Q
water at room temperature. Aliquots (0.5 µL) were removed at various time points and
placed in dry ice for 1 min after which they were mixed with 0.5 µL of MALDI matrix
solution. The premixed solution (0.5 µL) was spotted on an ABI-192-AB stainless steel
plate and allowed to dry at ambient temperature. The matrix solution consisted of 70 mg
of 3-hydroxypicolinic acid and 10 mg of ammonium citrate in 700 µL of 50% aqueous
acetonitrile. MS spectra were acquired in the reflector positive ion mode with an
accelerating voltage of 20 kV. Each spectrum was averaged by summing eight
subspectra, each of which consisted of 125 shorts/subspectrum.
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Exonuclease-Coupled MS Sequencing of Photoproduct I and Minor Photoproduct II with
Bovine Intestinal Mucosa Phosphodiesterase (BIMP)
BIMP was used for 3'→5' sequencing to locate the 3'-thymine of the photodimer
in both photoproduct I and minor II. In a typical sequencing experiment, the control or
photodamaged ODN (150 pmol) in 7 μL Milli-Q water was mixed with 1 μL BIMP in 10
mM Tris-HCl buffer with 50% Glycerol (pH 7.5) and digested at 37 ºC. Aliquots were
removed, spotted and finally analyzed by MALDI-TOF-MS as described for SVP
sequencing.
NP1-Coupled MALDI-TOF-MS Assay
NP1 digestion was carried out by adding 1 µL of 1 unit/ µL aqueous NP1 to 1.8
nmol of ODN in 10 µL of Milli-Q water. After 5 h at room temperature, the solution was
submitted to reverse phase HPLC using method C. The product eluting after the
mononucleotides was isolated, dried, and redissolved in MilliQ water to give a 50 µL
solution and mixed with an equal amount of the MALDI matrix. MS experiments were
carried out in the reflector positive ion mode as described above. MS/MS experiments
were carried out at medium pressure in the positive ion mode. The accelerating voltage
was 8 kV and 15 kV for source 1 and source 2, respectively; air was the collision gas.
Each spectrum was averaged by summing eight subspectra, each of which consisted of
125 shots/spectrum. Data were collected with the metastable ion suppressor on, and three
subspectra used for the precursor whose intensity was optimized. The precursor ion was
selected with a relative mass window that was 50-fold the specified resolution (full-width
at half-maximum peak height) of the selected precursor.
Glycosidic Bond Hydrolysis
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Acid-catalyzed glycosidic bond hydrolysis was carried out by adding 40 µL of
70% hydrogen fluoride in pyridine to 65 µg of ODN in a 1.5 mL polyethylene
microcentrifuge tube. The solution was incubated at 37 ºC for 3 h, diluted to 1 mL with
Milli-Q water, neutralized with 120 mg of calcium carbonate by vortexing for 5 min, and
filtered through an Xpertek 13 mm 0.45 µm nylon syringe filter (P.J. Cobert Associates,
Inc., St Louis, MO). The filtrate was evaporated in a SpeedVac (Thermo Savant,
Holbrook, NY) and redissolved in 100 µL of Milli-Q water for HPLC analysis with
method D. For the hydrolysis of authentic T[c,s]T and T[t,s]T dinucleotide intermediates,
23 µL of 70% hydrogen fluoride in pyridine was added to 45 µg of the dinucleotide
intermediate in a microcentrifuge tube and incubated in 37 ºC water bath for 3 h. The
hydrolysis solution was diluted to 600 µL of aqueous solution with Milli-Q water and
neutralized by adding 69 mg of calcium carbonate. After filtering and drying, the residue
was redissolved in 300 µL of Milli-Q water and analyzed by HPLC with method D. A
mixture of authentic thymine cyclobutane dimers for comparison was prepared by
irradiating 2 mM thymine in 5% acetone aqueous solution with UVB for 4 h as described
above for the ODNs.
ESI-MS and MS/MS Assay
ESI-MS and MS/MS experiments were carried out in the positive ion mode with
the ion-trap mass spectrometer. A solution of 80/20 (v/v) methanol/water with 0.1%
trifluoroacetic acid (TFA) was used as the spray solvent. The spray voltage was 4.6 kV.
The capillary voltage and temperature were 46 V and 200 ºC, respectively. MS/MS
experiments were done by using collision-activated dissociation (CAD) with helium as
collision gas. The mass window for precursor-ion selection was 3 m/z units. The collision
energy was 30% of the maximum value, corresponding to a peak-to-peak excitation
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voltage of 5 V. Approximately 20 scans were averaged for each spectrum. Each scan
consisted of 3 microscans with a maximum injection time of 300 ms.
NMR Analysis
Approximately 0.26 µmol of photoproduct I purified by HPLC method B was
dissolved in 100% D2O for 1D and 2D NMR analysis. Proton chemical shifts were
measured in parts per million (ppm) downfield from the H resonance of an internal 3(trimethylsilyl)propionic acid (TSP) standard, and
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P chemical shifts were measured

using trimethyl phosphate as an external reference. The total correlation (TOCSY)
spectra were recorded by using an MLEV-17 mixing sequence of 120 ms flanked by two
2 ms trim pulses. Phase-sensitive 2D spectra were obtained by employing the
hypercomplex method. A 2 ×256 ×2048 data matrix with 16 scans per t1 increment was
collected. Gaussian and sine-bell apodization functions were used in weighting the t2 and
t1 dimensions, respectively. After two-dimensional Fourier transformation, the 2048
×2048 frequency domain representation was phase and baseline corrected in both
dimensions. The NOESY spectrum resulted in a 2 × 256 × 2048 data matrix with 32
scans per t1 increment. Spectra were recorded with 80, 150, 250, and 450 ms mixing
times. The hypercomplex method was used to yield phase-sensitive spectra. The time
domain data were zero-filled to yield a 2048 × 2048 data matrix and were processed with
digital filtering to minimize the water signal. The proton-detected heteronuclear 1H-31P
HSQC spectrum was recorded by using a 20 ms delay period in the sequence. The 90º 1H
pulse width was 6.5 s, and the 90º
was set to 1500 Hz, and the
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P pulse width was 18 s. The proton spectral width

P spectral width was set to 700 Hz. Phase-sensitive 2D

spectra were obtained by employing the hypercomplex method. A 2 × 128 × 2048 data
matrix with 64 scans per t1 value was collected. Gaussian line broadening was used in
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weighting both the t2 and the t1 dimension. After two-dimensional Fourier transform, the
spectra (256 × 2048 data points) were phase and baseline corrected in both dimensions.

Results and Discussion
Our interest in the photochemistry of the 14-mer d(GTATCATGAGGTGC)
sequence was to prepare a T[c,s]C cyclobutane pyrimidine dimer for mechanistic studies
of C→T mutations. The sequence has a single adjoining dipyrimidine site and is devoid
of any stable secondary structure based on Watson Crick base pairing. Irradiation of the
ODN with UVB light led to the formation of two major photoproducts, I and II, with
retention times of 32.5 and 38.5 min, respectively, compared to 40.9 min for the starting
ODN (Figure 2.2A). Photoproduct I was produced with an unexpectedly high yield and
had an unusually short retention time compared to other known adjacent T=T
photoproducts. No such unusual products were previously observed when the identical
sequence containing a 5-methyl-CT site in place of the TC site had been irradiated (18).
In trying to understand why this TC sequence but not the previous mCT sequence led to
this unusual product, we discovered that the pH of the solution that was irradiated was
much lower than 7. A systematic study of pH (Figure 2.2B) showed that photoproduct I
was produced most efficiently at a pH of approximately 5, whereas photoproduct II was
favored at higher pH. MALDI-TOF analysis of the two photoproducts showed that they
both have the same mass (within 3 ppm) as the parent ODN, indicating that they are
isomeric photoproducts.
Photoreversal of Photoproducts I and II
Irradiation of photoproducts with 254 nm can be used to distinguish various
classes of DNA photoproducts. Cyclobutane dimers are reverted to the parent
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nucleotides, whereas Dewar photoproducts are reverted back to the parent (6-4)
photoproduct. When a pure sample of photoproduct II was irradiated with 254 nm light, it
was converted to the (6-4) photoproduct which could be identified by its characteristic
absorption at 325 nm (data not shown) (19, 20). This indicates that photoproduct II is
likely to be a Dewar valence isomer of the (6-4) product of the TC site. This was
confirmed by independently preparing the T(6-4)C photoproduct by 254 nm irradiation of
the parent ODN and converting the (6-4) photoproduct to its Dewar valence isomer by
irradiation with Pyrex-filtered medium pressure mercury arc light. When photoproduct I
was irradiated with 254 nm light, however, it was converted to the parent ODN (Figure
2.2C), suggesting that it was a cyclobutane dimer, or some other [2 + 2] cycloadduct, but
not of adjacent nucleotides, which would have a longer retention time.
Thermal and Hydrolytic Stability of Photoproduct I
C/mC-containing cis-syn cyclobutane pyrimidine dimer photoproducts readily
deaminate in neutral or acidic aqueous solution to afford U/T containing cis-syn dimers
(18, 21, 22). This deamination reaction is accompanied by an increase in mass of 1 u. MS
analysis of photoproduct I recovered after 1, 5, and 20 h of incubation at pH 4.8 at 37 ºC
revealed that the molecular weight was unchanged, excluding the possibility that
photoproduct I was a T[c,s]C product.
1

H NMR Analysis of Photoproduct I
Comparison of the aromatic region of the one-dimensional 1H NMR spectra of

photoproduct I and the parent ODN showed that the characteristic H6 protons of the two
Cs were present in both cases (confirmed by 2D NMR). On the other hand, two aromatic
TH6 protons were missing, consistent with cyclobutane dimer formation between two
nonadjacent Ts which would shift the H6 signal upfield (Figure 2.3). The two upfield
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shifted H6 protons could be identified through correlations to two methyl groups by 2D
NMR spectroscopy (vide infra) and had shifts of 3.59 and 3.62 ppm (Table 2.1).
Assignment of proton chemical shifts of the parent ODN and photoproduct I by TOCSY
and NOESY spectra
Cytosines were identified first by strong H5-H6 cross peaks (F, G, H, I of Figure
2.4 and Figure 2.5A). The unique AH8 (i) to CH1’ (i-1) NOE cross peaks of A6-C5 (E
and J, Figure 2.4A and Figure 2.5A) were then used to start the sequential analysis. The
base and sugar moieties are connected through intra-residue H6/H8 (i)-H1’/H2’2” (i)
cross-relaxation peaks while inter-residue H6/H8 (i)-H1’/H2’H2” (i)-H6/H8 (i+1)
pathways yield sequential assignment along the strand (Figure 2.4 and Figure 2.5).
Pyrimidine 5-CH3’s of the parent ODN were assigned by the intra-residue H8-5CH3
cross peaks and were also confirmed by the unique A3-T4 and A6-T7 inter-residue AH8
(i)-T5CH3 (i+1) NOE (Figure 2.4B). The assignment of H3’ and H4’ sugar protons were
made from the combined H3’ (i)-p-H4’ (i+1) backbone 1H-31P correlation (Figure 2.6A
and Figure 2.7A) with the sugar H1’ to H4’ spin propagation in TOCSY (Figure 2.6B and
Figure 2.7B). For instance, by tracing TOCSY T7-H3’ cross peak into the 1H-31P
correlated spectrum (73’ of Figure 2.6) can lead to the observation of the G8-H4’ (84’ of
Figure 2.6). The resonance of G8-H3’ (83’ of Figure 2.6B) can then be assigned by
further tracing the G8-H4’ back into the TOCSY spectrum. Comparing Figure 2.6A and
Figure 2.7A revealed that unusually downfield shifted 31P resonances at -2.7 and -2.15
ppm were observed in G1-p-T2 and A6-p-T7, respectively. Upfield shifted of T2, T7-H3’
(at 4.56 and 4.62 ppm) and downfield shifted of G8-H1’ (at 5.64 ppm) were also
observed in Figure 2.7B suggesting that the formation of T2=T7 dimer is indeed the
cause of the chemical shift changes in the neighboring residues.
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DNA Ladder Sequencing
To determine which two of the four nonadjacent Ts had photodimerized we used
a previously developed exonuclease-coupled MS method to map DNA damage sites. This
method employs phosphodiesterase type I and II enzymes to degrade ODNs from the 3'and 5'-directions, respectively, and MALDI to assay the fragments formed (23-26). This
method can map abasic sites and adjacent photodimers, both of which terminate the
progressive enzymatic cleavage (27-29). For 5'-exonucleolytic cleavage we used BSP,
which removes 3'-nucleotide monophosphates from DNA with a free 5'-OH. The activity
depends on contact with both the 5'- and 3'- bases flanking a phosphodiester bond,
although contact with a 3'-base is not absolutely required (30, 31). Digestion of the parent
ODN gave the expected fragments corresponding to the sequential loss of 3'-nucleotide
monophosphates (+ H2O - dNp) up to G11 in 5.5 min from which the majority of the
sequence could be confirmed (Figure 2.8A). When the same procedure was carried out
with BSP on photoproduct I (Figure 2.9A), excision of G1 was much slower than that of
normal nucleotides and degradation terminated immediately after loss of only G1,
indicating that one of the Ts involved in the unknown photodimer was T2. The reduced
activity of BSP for cleaving G1 of the photoproduct containing DNA is consistent with
the presence of a damaged base 3' to the phosphodiester bond which would interfere with
binding to the enzyme. Subsequent cleavage is then inhibited by the presence of a
damaged base that is 5' to the phosphodiester bond.
For 3'-exonucleolytic cleavage, we used SVP, which removes 5'-monophosphates
from the 3'-end by binding to the base to the 3'-side of the phosphodiester bond to be
cleaved (30). With the undamaged parental DNA, sequential excision of 5'-nucleotide
monophosphates (+ H2O - pdN) from the 3'-end was observed up to T4 in 5.5 min (Figure
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2.8B). With photoproduct I, sequential loss of seven nucleotides up to and including G8
was observed within the same time frame, indicating that T7 was the other base involved
in the photodimer which prevented the enzyme from binding T7 and cleaving to its 5'side (Figure 2.9B). Upon extended incubation for more than 1 h, however, a loss of 295 u
was observed, followed by successive losses corresponding to removal of pdT and pdC.
The loss of 295 u can be attributed to the sum of masses resulting from rate-limiting
endonucleotytic cleavage of the loop between the dimer at the A3T4 linkage (+ H2O),
presumably via binding to T4, followed by rapid 3'-exonucleolytic excision of pdA3 (+
H2O - pdA) (Scheme 2.1). Endonuclease activity is intrinsic to venom phosphodiesterase
(32) but is usually only observed in reactions with excess SVP or when long incubation
times are used (28, 33). Subsequent loss of pT4 and pdC5 could be explained by the
endonucleolytic cleavage steps after which no further enzymatic degradation occurred
since there were no more undamaged bases 3' to a phosphodiester bond.
Support for the proposed cleavage pathway and mechanism comes from SVP
degradation of the same photoproduct in a different sequence context in which A6 was
replaced by a G (Table 2.2, mut6). As with the original sequence, degradation occurred
rapidly until reaching T7, after which the same mass loss of 295 u corresponding to ratelimiting endonucleolytic cleavage of the loop between A3T4 followed by exonucleolytic
cleavage of pdA was observed, followed by loss of pT4 and pdC5 (Scheme 2.1).
Exonucleolytic cleavage of the photoproduct I in the original sequence context by BIMP,
another phosphodiesterase I enzyme used for DNA sequencing (34, 35), also resulted in
cleavage past T7. Unlike SVP, endonucleolytic cleavage of the loop took place at T4C5
and was followed by combined loss of pT by 3'-exonuclease activity and the 5'-phosphate
of C5 by a contaminating phosphatase. This was then followed by loss of pdA by 3'-
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exonuclease activity and then dC by endonuclease activity followed by rapid loss of the
5'-phosphate by the contaminating phosphatase (Figure 2.10).
NP1-Coupled MALDI-TOF MS Assay of Photoproduct I
To confirm that T2 and T7 are actually involved in the photoproduct, we used an
endonuclease-coupled MS assay that we previously developed to identify and quantify
adjacent dipyrimidine photoproducts (18, 36, 37). NP1 has both endonuclease activity
and 3'-phosphatase activity (38). It has a binding pocket that is specific for the bases in
DNA and, upon binding to the 5'-base, catalyzes hydrolysis of the phosphodiester bond to
yield deoxynucleotides with a 3'-hydroxyl group (30, 31, 39, 40). Because the bases in
dipyrimidine photoproducts are covalently linked together, NP1 cannot bind to either
base of the photoproduct and hence cannot cut to the 3'-side of either nucleotide of the
photoproduct. As a result, NP1 degradation of ODNs containing a dipyrimidine
photodimer of adjacent bases gives a photodimer-containing trinucleotide of the form
pd(Py=PyN). NP1 digestion of the parent ODN afforded, as expected, major products
corresponding to monomers eluting at 3.0 (pdC), 10.0 (pdT), 10.6 (dG), 11.0 (pdG), and
15.6 (pdA) min when using HPLC method C. NP1 digestion of photoproduct I, however,
gave an additional product eluting at 33.3 min. This component, after isolation, gave an
[M + H]+ by MALDI of m/z 1287.2347, which is within 3 ppm of the calculated value of
1287.2312 for pd(T[A])=pd(T[G]). Such a tetranucleotide can only result from NP1
digestion of a thymidine dimer formed between T2 and T7 or between T2 and T12, both
of which have Ts followed by an A and a G. Involvement of T4 is ruled out because it is
followed by C not G. Dimer formation between T2 and T12 is ruled out by SVP digestion
which showed no inhibition at T12 but did show an unusual product when degrading past
T7.To confirm the assignment of the NP1 digestion product to pd(T2[A3])=pd(T7[G8]),
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we carried out MALDI-TOF-MS/MS (Figure 2.11A). Key product ions were as follows:
[Ade + H]+ (m/z 136.1), [Gua + H]+ (m/z 152.1), [pdA + H]+ (m/z 332.1), [M - Ade + H]+
(m/z 1152.4), [M - Gua + H]+ (m/z 1136.4), and [M - pdG + H]+ (m/z 940.3). The other
product ions are also consistent with the structure as shown in the more detailed
fragmentation scheme in Figure 2.11B.
Stereochemistry of the Cyclobutane Dimer in Photoproduct I
To determine the relative stereochemistry of the nonadjacent dimer, the thymine
dimer was released from photoproduct I by acid-catalyzed glycosidic bond hydrolysis
and was compared with authentic samples of the four possible thymine dimers: cis-syn,
d,l-trans-syn, d,l-cis-anti, and d,l-trans-anti. The authentic products were produced by
sensitized UVB irradiation of thymine in aqueous acetone and separated by reverse phase
HPLC according to a recently described procedure (41). Thy[c,s]Thy, Thy[t,s]Thy,
Thy[c,a]Thy, and Thy[t,a]Thy were produced in nearly quantitative yield and eluted at
4.2, 5.2, 2.6, and 4.8 min, respectively, on reverse-phase HPLC with water (Figure 2.12B
left). ESI-MS confirmed them to be thymine dimers as all gave [M + H]+ ions of m/z
253.1. Irradiation of the mixture with 254 nm light prior to HPLC caused nearly
quantitative photoreversal of all the dimers back to thymine (Figure 2.12B, right).
To release the thymine dimer from photoproduct I, we used hydrogen fluoride in
pyridine which cleaves both the N-glycosidic and phosphodiester bonds of both
undamaged and photodimer-containing DNA without degrading the bases or the
photodimers (42-44). To test the method, we used authentic samples of d(T[c,s]T) and
d(T[t,s]T) dinucleotide intermediates used in the synthesis of photodimer building blocks
for DNA synthesis (45-47). The hydrolysis product of the cis-syn dimer eluted with the
component corresponding to peak 2 and while the hydrolysis product of the trans-syn
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dimer eluted with the component corresponding to peak 4, confirming our original
assignment of the thymine dimers based on their relative retention time (data not shown)
(41).

Hydrolysis

of

an

ODN

14-mer

containing

authentic

cis-syn

dimer

d(GTAT[c,s]TATGAGGTGC), gave peak 5 (Figure 2.12C, left) which eluted with the
same retention time as Thy[c,s]Thy. Photoreversal with 254 nm light resulted in
disappearance of the cis-syn dimer peak 5 and an increase in the thymine peak (Figure
2.12C, right). Hydrolysis of photoproduct I, however, released a product peak 6 (Figure
2.12A, left) which had the same retention time as the authentic Thy[c,a]Thy, establishing
it as a cis-anti thymine dimer. Photoreversal with 254 nm light, likewise, resulted in
disappearance of the dimer peak 6, and an increase in the thymine peak (Figure 2.12A,
right).To confirm further that photoproduct I has the cis-anti and not the cis-syn
stereochemistry, we compared the tandem MS of the hydrolysate of photoproduct I with
that of the cis-syn thymine dimer-containing ODN 14-mer, and the authentic Thy[c,a]Thy
(peak 1) and Thy[c,s]Thy (peak 2). The thymine dimer molecular ion [M + H]+ of m/z
253.1 is known to undergo different fragmentation for the cis-syn and cis-anti
stereoisomers (48). MS/MS of the cis-syn stereoisomer produced a most abundant m/z
210.0 ion by loss of CHNO (43 u) whereas the cis-anti stereoisomer produced a most
abundant ion of m/z 127.1, suggesting that reversion to thymine occurs under the
collision activation conditions (Figure 2.13). Reversion of the cis-anti, but not the cis-syn
isomer, during MS/MS is consistent with the thermal instability of the anti stereoisomers
compared to the syn stereoisomers (41, 49). MS/MS of the precursor ion of m/z 253.1
produced by photoproduct I hydrolysate afforded the ion of m/z 127.1 characteristic of
the cis-anti stereochemistry.
Absolute Stereochemistry of Photoproduct I by 2D NMR Analysis
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We assigned proton chemical shifts of the parent ODN and photoproduct I by a
standard sequential assignment strategy based on TOCSY and NOESY spectra (Figure
2.14 and Figures 2.4,2.6 and 2.7). The assignments confirm that the photodimer formed
between T2 and T7. Owing to a loss of aromaticity of the T2 and T7 bases upon the
formation of the cyclobutane dimer, the chemical shift of the H6 protons were
significantly shifted upfield. As a result, intraresidue aromatic H6-CH3 cross-peaks were
not observed for T2 and T7 but were observed for T4 and T12 (Figure 2.5B). Likewise,
aromatic H6/H8 (i)-H1' (i-1) cross-peaks used in the sequential assignment of DNA were
not observed for T2-G1 and T7-A6 (Figure 2.5A).
The methyl groups of the thymine dimer were assigned based on the observable
G1 H1'/H3'-T2CH3 and A6 H1'/H3'-T7CH3 cross-peaks located in the most upfield
shifted methyl region (Figure 2.14B,C). The H6s of the thymine dimer were then
assigned by tracing two intraresidue H6-5CH3 cross-peaks between 3.5-3.7 ppm and 1.31.4 ppm (Figure 2.14D). The corresponding intraresidue T2/T7 H6-H2'2'' NOEs were
used to reestablish the sequential A3-T2 and G8-T7 pathway through the joint vertical
line in the 1.8-2.0 ppm region (Figure 2.14A,D). In this way, T2H6 could be assigned to
3.59 ppm and T7H6 to 3.62 ppm. The observation of four strong T2/T7 H6-CH3 crosspeaks (Figure 2.14D, dotted box a) is consistent with a cis-anti stereochemistry for the
dimer for which each H6 proton is within NOE distance of each of the methyl groups
(Figure 2.15A). A cis-syn dimer, on the other hand, generally shows only three crosspeaks because of the puckered ring conformation which results in one long, NOE inactive
H-CH3 distance. Likewise, a trans-syn or trans-anti dimer generally shows only two
cross-peaks. The presence of T2H1'-T7CH3 and T7H1'-T2CH3 (Figure 2.14B, dotted box
c) and T2H1'-T2H6 and T7H1'-T7H6 (Figure 2.14B, dotted box d) cross-peaks and the
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absence of T2H1'-T7H6 and T7H1'-T2H6 cross-peaks is also consistent with an anti
orientation of C5-C6 bonds of the dimer as illustrated for Structure I in Figure 2.15B.
Given the cis-anti stereochemistry of the cyclobutane dimer, there are still four
possible structures of the T2[c,a]T7 photoproduct to consider (Figure 2.15B). Structures I
and II would result from photodimerization of the two Ts in anti glycosyl conformations
with either a 5'- or 3'-staggered stacking arrangement. Structures III and IV would result
from photodimerization of the two Ts in a syn glycosyl conformation with either a 5'- or
3'-staggered stacking arrangement. The presence of a cross-peak between A3H8 and
T7CH3 (Figure 2.14A, dotted box e) is consistent with either structure I or III which
places T7 near A3 (Figure 2.15B, Structure I). The presence of a strong intraresidue
cross-peak between H6-H2'2'' for both T2 and T7 (Figure 2.14D, dotted box b) at various
mixing times ranging from 80 to 450 ms is consistent with an anti glycosyl conformation
of structure I but not structure III (Figure 2.15B), strongly suggesting that the
photoproduct has structure I.
Photoreversion of Minor I and Minor II
The UVB irradiation mixture of d(GTATCATGAGGTGC) produced at pH 3.6
was irradiated with 254 nm light for 30 min. HPLC assay showed that both minor I and
minor II disappeared and were presumably converted to the parent ODN (Figure 2.16),
suggesting that the two minor photoproducts are cyclobutane dimers.
NP1-Coupled MALDI-TOF MS Assay of Minor I and Minor II
NP1 digestion was carried out on the minor I and minor II photoproducts
followed by MALDI-TOF-MS with default calibration. For the minor I photoproduct a
molecular ion [M+H]+ was detected at m/z 1247.4 corresponding to pd(T[A])=pd(T[C])
and for the minor II photoproduct a molecular ion was detected at m/z 1287.4
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corresponding to pd(T[A])=pd(T[G]). Further MALDI-TOF-MS/MS experiments
confirmed the assignment of the minor I digestion product by the presence of [Cyt + H]+
at m/z 112.1 and [Ade + H]+ at m/z 136.1 (Figure 2.17A). Likewise, assignment of the
minor II digestion product was confirmed by the presence of [Ade + H]+ at m/z 136.1 and
[Gua + H]+ at m/z 152.1 (Figure 2.17B). The results suggest that the thymine dimer of
minor I is formed between T2 and T4 and that of minor II is between T2 and T7 or T2
and T12.
DNA Ladder Sequencing of Photoproduct I and Minor Photoproduct II with BIMP
Photoproduct minor II was seen having exactly the same digestion ladder pattern
(Figure 2.18) as photoproduct I (Figure 2.10A) and could be explained in the same way
(Figure 2.10B). After sequential removal of C14 to G8, exonuclease degradation was
inhibited at T7. A mass loss of 366.1 u was observed immediately after loss of G8, which
corresponds to addition of water by hydrolysis of the T4C5 phosphodiester bond by its
minor endonuclease activity and then loss of T4 by its exonuclease activity along with 5'HPO3 of C5 by the 5'-phosphatase activity that must contaminate the commercial
preparation of BIMP. The enzyme then excised A3 by its 3'-exonuclease activity. Finally
the degradation terminated at m/z 1127.2 after a loss of and dC5 by its endonuclease
activity, and 5’-HPO3 of A6, indicating that the dimer of minor II is formed between T2
and T7.
Cyclobutane Dimer Stereochemistry of Minor I and Minor II
Two minor photoproducts, minor I and minor II (Figure 2.2A), were also
analyzed by NP1-coupled MS/MS and exonuclease-coupled MS sequencing and by
comparison of acid hydrolysates to the authentic thymine dimers (Figure 2.16-2.20).
Hydrolysis of the minor I and minor II photoproducts with hydrogen fluoride in pyridine
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released products that had the same retention time as the authentic cis-syn thymine dimer
and as the authentic trans-anti thymine dimer, respectively (Figure 2.19). The molecular
ions [M + H]+ of the hydrolysates of both the minor I and minor II photoproducts were
detected at m/z 253.1 by ESI-MS. ESI-MS/MS of the hydrolysate of the minor I
photoproduct gave the same base peak of m/z 210.0 as with that of authentic Thy[c,s]Thy
(Figure 2.20A). ESI-MS/MS of the hydrolysate of the minor II photoproduct, however,
gave a base peak of m/z 208.0 and another intense peak at m/z 127.1 that was also
observed for authentic Thy[t,a]Thy (Figure 2.20B). On the basis of these data, minor I
was assigned to a T2[c,s]T4 nonadjacent dimer, and minor II to a T2[t,a]T7 nonadjacent
dimer.
Photodimerization in Different Sequence Contexts and Concentrations
To determine the sequence specificity of the photodimerization reaction resulting
in the T2[c,a]T7 product, we irradiated an additional ten ODNs corresponding to sitespecific mutations within the loop region, and deletions of the sequence to the 3'-side of
the photoproduct (Table 2.2) at pH 4.8. Only irradiation of mut6, in which the A
preceding T7 was mutated to G produced the T2[c,a]T7 nonadjacent dimer in a similar
high yield as the parent sequence (Figure 2.21). The requirements for having A3, T4, C5,
G8 and the 3'-end of the sequence to produce the photoproduct in high yield indicates
that a set of highly specific base pairing interactions are required to form the necessary
folded structure.To determine whether the folded structure leading to the photoproduct
was intramolecular or involved the assembly of two or more strands, we determined the
photoproduct yield at two different concentrations. To ensure that the DNA in the two
samples absorbed the same amount of light, we used samples that differed in
concentration by a factor of 10 and placed them in quartz cuvettes with 0.1 and 1 cm
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pathlengths, so that they each had an absorbance of 0.3 at 260 nm corresponding to
absorption of 50% of the incident light. Thus 100 µL of a 20 µM solution at pH 4.8 in a
0.1 cm path length quartz cuvette and 1000 µL of a 2 µM solution in a 1 cm cuvette were
irradiated side by side for 1 h with ice cooling to give the product in 32% and 14%
yields, respectively, indicating that the folded structure involves two or more strands.

Conclusions
On the basis of the photoreactivity, spectroscopy, and spectrometry data, we
determined the structure of the new photoproduct to be a nonadjacent cis-anti
cyclobutane dimer formed between T2 and T7 with the absolute stereochemistry depicted
by structure I (Figure 2.15). This is the first interstrand type of cyclobutane dimer to be
isolated and characterized in DNA. There is no predictable stable Watson-Crick folded
structure of d(GTATCATGAGGTGC) that can explain the high yield formation of this
product. On the basis of our mutagenesis and concentration studies, we speculate that the
sequence adopts a higher order folded structure at pH 5 by inter- and intramolecular base
pairing between strands, which remains to be elucidated. The formation of this
interstrand photoproduct also suggests that such type of photoproducts might also form in
biologically important higher order DNA structures such as between loops of G-quartet
structures in telomeres and promoters and between strands in i-motif structures (16, 17).
The methods described herein could be used to identify and map such photoproducts
which could be used as a probe to distinguish between various folding structures in
solution and in vivo. Once the structure-activity relationships of interstrand photoproduct
formation are better understood, it is conceivable that it could also be used for the
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assembly and/or characterization of higher order DNA structures for nanotechnological
applications.
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Table 2.1. Proton and 31P chemical shifts of the parent ODN and photoproduct I in D2O
at 25 oC.

H6/H8
H5/CH3
H1’
H2’2’

H3’
H4’
31

P

G1 T2 A3 T4 C5 A6 T7 G8 A9 G10
parent 7.85 7.37 8.34 7.36 7.53 8.34 7.22 7.78 8.08 7.75
cis-anti 7.87 3.59 8.18 7.69 7.52 8.16 3.62 7.84 8.12 7.74
parent
1.67
1.66 5.91
1.64
cis-anti
1.29
parent 6.08 6.02 6.28
cis-anti 6.22 5.94 6.33
parent 2.63 1.95 2.77
2.27
cis-anti 2.66 1.91 2.79
2.81 1.96
parent 4.85 4.81 4.97
cis-anti 4.96 4.56 5.04
parent 4.23 4.18 4.4
cis-anti 4.27 4.12 4.44
G1-2 G2-3 G3-4
parent -3.08 -3.06 -3.24
cis-anti -2.7 -2.83 -3.04

T12
7.29
7.31
1.63

G13 C14
7.94 7.76
7.94 7.75
5.87

4.89
4.89
4.27
4.27
G10-11

5.94
5.97
2.6
2.66
2.58
2.67
4.94
4.93
4.34
4.32
G11-12

1.65
5.96
6.04
1.91
2.29
1.93
2.29
4.79
4.77
4.16
4.15
G12-13

6.07
6.11
2.61
2.72
2.63
2.73
4.95
4.93
4.33
4.32
G13-14

-2.99 -3.13 -3.24 -3.31 -3.11 -3.22 -3.05
-2.78 -3.04 -2.14 -3.21 -3.22 -3.23 -3.03

-3.16
-3.14

-3.18
-3.18

-2.82
-2.81

1.85
6.04
6.34
2.11
2.34
2.31
2.51
4.8
4.87
4.23
4.39
G4-5

5.95
5.97
6
1.79
2.26
1.45
2.13
4.75
4.68
4.15
4.15
G5-6

1.38
6.27 5.86 5.45 5.95
6.22 6.01 5.64 5.97
2.74 1.73 2.4 2.52
2.11
2.65 1.81 2.45 2.55
2.79 1.9
4.98 4.72 4.82 4.92
5.03 4.62 4.87 4.93
4.39 4.1 4.17 4.17
4.36 4.13 4.23 4.32
G6-7 G7-8 G8-9 G9-10
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5.64
5.67
2.42
2.41

G11
7.86
7.86

5.87
6.21
6.24
2.25
2.39
2.25
2.37
4.55
4.54
4.13
4.12

Table 2.2. Photoproduct yields for mutant sequences of d(GTATCATGAGGTGC).
ODNs (50 µM) were irradiated at pH 4.8 for 2.5 h at 0 ºCa,b.

a

Mutations are underlined.

b

Only photoproducts detected in greater than 3% yield are reported.
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Figure 2.1. Photochemistry of DNA. (A) Structures of the major type of photoproducts.
(B) Intra- and (C) interstrand-type photoreactions, both of which lead to nonadjacent
photoproducts, except when n = 0 for B, which results in an adjacent photoproduct.
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Figure 2.2. HPLC analysis of photoproduct formation and reversal. (A) Reverse phase
HPLC

analysis

with

method

A

of

a

UVB

irradiation

mixture

of

d(GTATCATGAGGTGC) at different pHs. Accurate m/z of the molecular ion [M + H]+
of the unknown photoproduct I is 4317.7778 with mass error of +3.1 ppm compared with
a calculated value of 4317.7644. (B) Plot of the percent yield (calculated by peak area) of
photoproduct I and the photoproduct II-Dewar photoproduct as a function of pH. The
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error bars represent the standard deviation of three independent experiments. (C) Reverse
phase HPLC analysis with method B of the products of 254 nm irradiation of
photoproduct I for 0, 3, and 6 min. The major reversion product was confirmed to be the
parent ODN by MALDI analysis of the PDE I and PDE II digestion products. The
smaller peaks eluting around 32 min are attributable 254 nm irradiation products of the
reversal product, as confirmed by separate irradiation of the parent ODN.
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Figure 2.3. NMR spectra of photoproduct I and the parent ODN. 1D 1H NMR spectra of
the aromatic region of (A) the parent ODN d(GTATCATGAGGTGC) and (B)
photoproduct I at room temperature in D2O. The spectra show that two of the four
aromatic TH6 proton signals are missing in photoproduct I, indicating formation of a
T=T photoproduct.
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Figure 2.4. NOESY subspectra of the parent ODN. Expansion from the aromatic H6/H8
region to (A) H1’/H5 and (B) H2’2”/TCH3 region of 600 MHz NOESY spectrum of the
parent ODN 14-mer in “100%” D2O at 25 °C. Sequence of A3 through A9 is connected
by line with number that represents (A) H6/8 (i)-H1’(i), and (B) H6/8 (i)-H2’2”/TCH3 (i)
crosspeaks.
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Figure 2.5. NOESY subspectra for photoproduct I. Expansion from the aromatic H6/H8
region to H1’/H5 and H2’2”/T-5CH3 region of 600 MHz NOESY spectrum of
photoproduct I 14-mer at 25 °C. Sequence is connected by line with number represents.
A) H6/H 8 (i)-H1’ (i), and B) H6/H8 (i)-H2’2”/T-5CH3 (i) cross peaks.
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Figure 2.6. 1H-31P HSQC and TOCSY subspectra of the parent ODN. A) 1H-31P HSQC
spectrum of the parent ODN 14-mer in “100%” D2O. Horizontal line connections
represent H3’ (i)-p-H4’ (i+1) correlation. B) Expanded H3’/H4’ region of TOCSY
spectrum. Horizontal line connections represent H3’-H4’ spin propagation.
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Figure 2.7. 1H-31P HSQC and TOCSY subspectra of photoproduct I. A) 1H-31P HSQC
spectrum of photoproduct I in “100%” D2O. Horizontal line connections represent
H3’(i)-p-H4’(i+1) correlation, B) Expanded H3’/H4’ region of TOCSY spectrum.
Horizontal line connections represent H3’-H4’ spin propagation.
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Figure 2.8. Exonuclease-coupled MS ladder sequencing of the parent ODN. A) BSP
digestion (5'→3') coupled MALDI sequencing at room temperature for 0.5, 1.5, and 5.5
min (top to bottom). B) SVP digestion (3'→5') coupled MALDI sequencing at 37 °C for
1, 2.5, and 5.5 min (top to bottom). An asterisk refers to a doubly charged ion.
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Figure 2.9. Exonuclease-coupled MS ladder sequencing of photoproduct I. (A) BSP
digestion coupled MALDI sequencing at room temperature for 0 min, 110 min, and at 37
ºC for 40 min (top to bottom). (B) SVP digestion coupled MALDI sequencing at 37 ºC
for 1, 2.5, 5.5, and 85 min (top to bottom). The mass losses of 289.05, 304.05, 313.06,
and 329.05 u correspond to exonucleotytic cleavage of pdC, pdT, pdA, and pdG,
respectively (+ H2O - pdN). Nucleotides that were enzymatically removed are
represented by small-case letters. Peaks labeled with * are doubly charged digestion
fragments. indicates photodamaged ODNs. Proton signals are missing in photoproduct I,
indicating formation of a T=T photoproduct.
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Figure 2.10. BIMP sequencing of photoproduct I. A) BIMP digestion (3'→5') coupled
MALDI sequencing of photoproduct I at 37 °C for 0.5 min, 7 min, and 110 min (top to
bottom). The mass loss of 289.05, 304.05, 313.06, and 329.05 u corresponding to the
excision of pdC, pT, pdA, and pdG, respectively (+ H2O - pdN). Nucleotides that were
enzymatically removed are represented by small-case letters. Right: proposed enzymatic
cleavage pathway by BIMP for photoproduct I.
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Figure 2.11. Mass spectrometry analysis of the NP1 digestion product of photoproduct I.
(A) MALDI-TOF-MS/MS spectrum of parent ion [M+H]+ (m/z 1287.3) of HPLC purified
ultimate NP1 digestion product of photoproduct I. (B) Proposed fragmentation pathway.
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Figure 2.12. Structure correlation of the cyclobutane thymine dimer. The acid hydrolysis
products of photoproduct I were compared to an authentic mixture of cyclobutane
thymine dimers by HPLC using method D. HPLC traces of (A) the acid hydrolysis
products of photoproduct I, (B) the product mixture from the irradiation of thymine, and
(C) the acid hydrolysis products of the cis-syn TT dimer containing photoproduct
d(GTAT[c,s]TATGAGGTGC). To the left are the HPLC traces before irradiation with
254 nm light, and to the right, after irradiation. The peaks labeled with U/A are
unassigned peaks.
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Figure 2.13. ESI-MS/MS characterization of the cyclobutane thymine dimers. A)
Thy[c,a]Thy

dimer

from

photoproduct

d(GTAT[c,s]TATGAGGTGC).

59

I

and

B)

Thy[c,s]Thy

dimer

from

Fig. S3. ESI-MS/MS of (A) HPLC peak n-1 (n = 1, 2, and 3), pd[T=UA] and (B) HPLC
peak n -2 (n = 1, 2, and 3), pd[T=AG] corresponding to the TA* photoproduct.

Figure 2.14. Section of NOESY spectra of photoproduct I at 25 ºC. (A) Cross-correlation
between the H6, sugar, and methyl protons of T2 and T7. (B) Connection of the
preceding G1, A6-H1', T2, T7-H1' to T2/T7 methyl protons. (C) Connection of the
preceding G1, A6-H3' to T2/T7 methyl protons. (D) Connection of the T2/T7
H6H2'2''/CH3 protons. See text for explanation of the cross-peaks enclosed in the dotted
boxes.
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Figure 2.15. Structure and stereochemistry of the cis-anti stereoisomers of the T2[c,a]T7
product. (A) Conformations of the cyclobutane ring of cis-anti, cis-syn, trans-syn, transanti thymine dimers and the NOE active H6-CH3 pairs. (B) The four possible cis-anti T2T7 cyclobutane dimers showing how the observed NOEs are consistent with structure I.
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Figure 2.16. Photoreversal of UVB irradiation products to the parent ODN. Reverse
phase HPLC analysis (method B) of the photoproducts of d(GTATCATGAGGTGC)
produced at pH 3.6 to the parent ODN with 254 nm light: A) UVB irradiation mixture of
d(GTATCATGAGGTGC) produced at pH 3.6, and B) UVB irradiation mixture of
d(GTATCATGAGGTGC) produced at pH 3.6 after 30 min irradiation with 254 nm light.
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Figure 2.17. Mass spectrometry analysis of NP1 digestion product of minor I and minor
II. MALDI-TOF-MS/MS spectra of: A) the parent ion [M+H]+ (m/z 1247.4) of HPLC
purified ultimate NP1 digestion product of minor I, c,s-pd(T[A])=pd(T[C]), showing loss
of [Ade+H]+ at 136 and [Cyt+H]+ at 112, and B) the parent ion [M+H]+ (m/z 1287.4) of
HPLC purified ultimate NP1 digestion product of minor II, t,a-pd(T[A])=pd(T[G])
showing the same fragments as for photoproduct I (Figure 2.11).
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Figure 2.18. BIMP digestion (3'→5') coupled MALDI sequencing of minor photoproduct
II. Minor photoproduct II was treated with BIMP at 37 °C for A) 1 min, B) 7 min, and C)
110 min. The mass loss of 289.05, 304.05, 313.06, and 329.05 u corresponds to the
excision of pdC, pT, pdA, and pdG, respectively (+H2O-pdN). Nucleotides that were
enzymatically removed are represented by small-case letters.
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Figure 2.19. Thymine dimer stereochemistry of minor photoproducts I and II by
chemical correlation. Comparison of cyclobutane dimers of thymine with the acid
hydrolysis products of minor I and minor II photoproducts by reverse phase HPLC
(method D). HPLC traces of: A) the hydrolysates of minor I, B) the product mixture from
the irradiation of thymine, C) the hydrolysates of minor II.
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Figure 2.20. ESI-MS/MS characterization of the cyclobutane thymine dimers. A)
Thy[c,s]Thy dimer from minor I. B) Thy[t,a]Thy dimer from minor II.
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Figure 2.21. Formation and identification of the T2[c,a]T7 product in the mut6 sequence.
Reverse phase HPLC analysis with method B of the UVB irradiation mixture of A)
d(GTATCGTGAGGTGC) at pH 4.8, and B) MALDI-TOF-MS/MS assay of HPLC
purified ultimate NP1 digestion product of T2[c,a]T7 non-adjacent photoproduct of
d(GTATCGTGAGGTGC).
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Scheme 2.1. Proposed enzymatic cleavage pathway by SVP for the T2[c,a]T7
photoproducts of the original sequence and mut6 (A6G).
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Chapter 3

Photocrosslinking of Human Telomeric Gquadruplex Loops by Anti Cyclobutane
Thymine Dimer Formation

69

Abstract
The unusual structural forms of telomere DNA, which protect the ends of
chromosomes during replication, may render it vulnerable to unprecedented
photodamage, possibly involving nonadjacent bases that are made proximate by folding.
The G-quadruplex for the human telomere sequence consisting of a repeating
d(TTAGGG) is one unusual form. Tel22, d[AGGG(TTAGGG)3], forms a basket
structure in the presence of Na+ and may form multiple equilibrating structures in the
presence of K+ with hybrid-type structures predominating. UVB irradiation of
d[AGGG(TTAGGG)3] in the presence of Na+ results in a cis,syn thymine dimer between
two adjacent Ts in a TTA loop and a mixture of nonadjacent anti thymine dimers
between various loops. Irradiation in the presence of K+, however, produces, in addition
to these same products, a large amount of specific anti thymine dimers formed between
either T in loop 1 and the central T in loop 3. These latter species were not observed in
the presence of Na+. Interloop-specific anti thymine dimers are incompatible with hybridtype structures, but could arise from a chair or basket-type structure or from triplex
intermediates involved in interconverting these structures. If these unique nonadjacent
anti thymine dimer photoproducts also form in vivo, they would constitute a previously
unrecognized type of DNA photodamage that may interfere with telomere replication and
present a unique challenge to DNA repair. Furthermore, these unusual anti photoproducts
may be used to establish the presence of G-quadruplex or quadruplex-like structures in
vivo.
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Introduction
Telomeres are repetitive sequences at the ends of chromosomes that function in
concert with telomerase and a number of other proteins to protect the ends of
chromosomes from shortening during successive rounds of replication (1-3). The human
telomere sequence consists of repeating d(TTAGGG) that may fold into various repeating
G-quadruplex structures. Short fragments of the human telomere sequence can exist in a
myriad of structures that depend on their sequence and on the cations present (4-7). To
date, basket (8, 9), parallel (10), and (3 + 1) structures including hybrid-1 and hybrid-2
(11-14) type G-quadruplex forms have been determined by NMR and crystallography.
The oligodeoxynucleotide, d[AGGG(TTAGGG)3] (Tel22), adopts a basket structure in
solutions containing Na+ (8), whereas in the presence of K+, the predominant intracellular
cation, the hybrid-type structures are favored over the basket (11, 13) and/or chair (15)
structures (Figure 3.1).
In chapter 2, we describe a highly unusual interstrand-type nonadjacent, anti
thymine photodimer (Figure 3.2B), previously only found in dried or ethanolic solutions
of UVC irradiated DNA (16), can form in aqueous solution. Irradiation of
d(GTATCATGAGGTGC) with UVB light produced a high yield of cis,anti thymine
photodimer between T2 and T7 under slightly acidic conditions (17). This anti
photodimer must originate from some folded structure, still unknown, that brings T2 in a
head to tail arrangement with T7 followed by photoinduced [2 + 2] cycloaddition
reaction between the two 5, 6 double bonds. An important implication of this observation
is that anti thymine photodimers might also form in G-quadruplex forms of human
telomeric DNA. Among the various G-quadruplex structures that could lead to anti
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thymine photodimers are the basket and chair structures, which have two lateral TTA
loops in close proximity. Other structures, such as the parallel and hybrid structures do
not have proximate loops, suggesting that photochemical reactions such as this may be
developed as structural probes even in vivo.
To our knowledge, the photochemistry of native human telomeric DNA has never
been investigated, although the photoinduced hydrogen abstraction reactions of
iodouracil substituted telomeric DNA has been reported (18). In 1989, however, Cech
and coworkers did report the formation of crosslinks upon 254 nm irradiation of the
folded form of the closely related Oxytricha, d(T4G4)4, and Tetrahymena d(T2G4)4
telomeric sequences as evidence for a G-quartet structure (19). The photocrosslinks
formed in the presence of Na+ were found to occur primarily between T11 and T27 in
d(T4G4)4 and between T1 or G3 and T13 in d(T2G4)4 by gel electrophoresis of chemical
cleavage products, and were ascribed to G-quartet chair structures. The structures of the
photoproducts involved in the crosslinking, however, were never determined. In this
chapter, we describe that irradiation of G-quadruplex forms of the human telomeric
sequence d[AGGG(TTAGGG)3] (Tel22) with biologically relevant UVB light (280-320
nm) and in the presence of the biologically relevant cation K+ results in a significant
amount of anti thymine dimers between either T in loop 1 with the central T in loop 3.
We also discuss the mechanistic and biological implications of these findings.

Material and Methods
Preparation of G-Quadruplexes
Typically, 50 µM ODN (IDT) in 10 mM Tris-HCl, pH 7.5, with 150 mM KCl or
NaCl was heated at 95 ºC for 5-10 min and then either rapidly cooled down in ice or
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slowly cooled to room temperature over a couple of hours and then cooled in ice. The
formation of G-quadruplexes was confirmed by Circular Dichroism (CD) (Figure.3.3).
CD Experiments
Formation of G-quadruplexes was monitored by CD. Samples were measured
immediately after the preparation or after storage for hours to days at 4 ºC. All of the CD
spectra were recorded on a J-810 spectropolarimeter (Jasco). The measurements were
carried out with 100 µL of 50 µM ODN samples in a 1-mm path quartz cell at 4 ºC under
nitrogen to prevent water condensation. Spectra shown (Figure. 3.3) were the average of
3 accumulations in a range from 220 to 300 nm with a band width of 1 nm, response time
of 1 s, data pitch of 0.2 nm, and scan speed of 50 nm/min. A blank sample of 10 mM
Tris-HCl buffer, pH 7.5, with 150 mM KCl or NaCl was used for baseline correction.
Polyacrylamide Gel Electrophoresis (PAGE) Experiments
The 5’ termini of the oligodeoxynucleotides were labeled by a forward reaction
with 1 × reaction buffer (500 mM Tris HCl, pH 7.6, 100 mM MgCl2, 50 mM DTT, 1
mM spermidine, 1 mM EDTA; Fermentas Life Science) with 10UT4 polynucleotide
kinase and 20 pmol [γ-32P]-ATP at 37 ºC for 30 min. The reaction was quenched by
adding to an equal volume of 2 × loading buffer (98% formamide, 10 mM EDTA),
boiling for 2 min, and cooling on ice for another 1 min. The radiolabeled samples were
then analyzed on a 15% denaturing polyacrylamide gel and scanned with a
PhosphorImager (Bio-Rad Laboratories).
UVB Irradiation
UVB irradiation (280-400 nm with peak intensity at 312 nm) was carried out with
two Spectroline XX-15B UV 15-W tubes (rated UV intensity of 1.15 mW/cm2 at 25 cm)
filtered by a LONGLIFE filter (Spectronics Corporation) immediately after sample
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preparation or after storage at 4 ºC for overnight to days with similar results. Gquadruplex samples were enclosed in a polyethylene Ziplock bag and irradiated on a bed
of ice for 22.5 h at a distance of 1 cm from the UVB lamp.
NP1 Digestion
Typically, 1 µL 1 U/µL aqueous NP1 from Penicillium citrinum (Sigma) and 1
µL 10 mM ZnCl2 were added to 100 µL 50 µM UVB irradiation samples and digested at
37 ºC for >36 h. Digested samples were then converted to the ammonium form for mass
spectrometry by mixing with the ammonium form of Dowex resin (Sigma).
HF/Pyridine Hydrolysis
Typically, 8 µL 70% HF/pyridine (Sigma) were added to 15 µg dry NP1 digestion
product in a polyethylene microcentrifuge tube and incubated at 37 ºC. After 2.5 h, the
sample was diluted to 300 µL with Milli-Q water, neutralized with 30 mg calcium
carbonate and filtered through an Xpertek 13-mm 0.45-µm nylon syringe filter (P.J.
Cobert Associates). The filtrate was evaporated and redissolved in Milli-Q water before
HPLC analysis.
HPLC Analysis
Reverse-phase HPLC was carried out with an X-Bridge column (C18, 4.6 × 75
mm, 2.5 µm, 135 Å Waters Corporation) on a System Gold BioEssential HPLC with a
Model 125 binary gradient pump and a Model 168 diode array detector (Beckman
Coulter). NP1 digestion products were analyzed with a 1 mL/min gradient of 100% A (50
mM triethylammonium acetate, pH 7.5) for 3 min and 0%-20% B for 3-53 min (50%
acetonitrile in 50 mM triethylammonium acetate, pH 7.5) and detected at 260 nm.
HF/pyridine hydrolysis products were analyzed with an isocratic gradient of 100% MilliQ water and detected at 205 nm.
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ESI-MS Experiments
Intact/whole-length ODN samples were analyzed in the positive-ion mode on a
Waters Micromass Q-Tof Ultima spectrometer. The Z-Spray source was operated at 2.8
kV, the cone voltage was 150 V, and RF lens was 50. The source temperature and
desolvation temperatures were 80 ºC and 180 ºC, respectively. The collision energy was
10 eV, and the MCP detector was 2,200 V. Spray solvent was 30 mM ammonium acetate
in 20% methanol. ODNs from NP1-coupled HPLC separation were analyzed in the
negative-ion mode with a Thermo Finnigan LTQ-FT mass spectrometer (Thermo Fisher
Scientific). A solution of 50/50 (vol/vol) methanol/water was used as the spray solvent.
The spray voltage was 3.5 kV. The capillary voltage and temperature were 46 V and 250
ºC, respectively. MS/MS experiments were done by using CAD with helium as the
collision gas. The mass window for precursor-ion selection was 2.5 m/z units. The
normalized collision energy (15% of the maximum) was adjusted to obtain product ions
of good signal-to-noise ratio. At this setting, nearly all of the precursor ions had
fragmented.

Results
To determine whether nonadjacent photoproducts can be produced in the Gquadruplex forms of the human telomere, we analyzed the irradiation products of the 22mer fragment, d[AGGG(TTAGGG)3] (Tel22) and its derivatives by an enzyme-coupled
mass spectrometry assay (17, 20). This 22-mer fragment was initially chosen because it
adopts the basket form in Na+ solution (8), which was expected to lead to efficient
photocrosslinking between loops 1 and 3. To determine which nucleotides were involved
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in photoproduct formation, we substituted various Ts with Us, which have the same
photochemical and base pairing properties but differ in mass.
Formation and Irradiation of Telomeric G-Quadruplex
To prepare the G-quadruplexes, ODNs were first denatured and then either cooled
quickly or slowly to 0 ºC with similar results, which is consistent with a rapid rate of
folding (21). The circular dichroism (CD) spectra of Tel22 in Na+ and K+ closely
matched previously reported spectra (Figure 3.3). The CD spectra for Tel22 in Na+
(Figure 3.3A) most closely matched those reported by Li et al., Xu et al., and Gray et al.
(15, 22, 23) but differed from those reported by Vorlickova et al. and Ambrus et al. (11,
24) in the relative magnitude of the 263 nm peak to the 297 nm peak. Likewise, the
spectra for Tel22 in K+ solution (Figure. 3.3B) most closely matched those reported by
Ambrus et al., Vorlickova et al., and Gray et al. (11, 23, 24) but differed somewhat from
that reported by Li et al. (22) and more so from that reported by Xu et al. (15). These
differences, their origin, or their significance, have not, to our knowledge, been addressed
in the literature. The CD spectrum for Tel26 in K+ solution (Figure. 3.3C) matched
closely to that reported by Ambrus et al. (11). ODNs in which a U was substituted for a T
(Figure 3.2A) gave similar CD spectra to those of Tel22. Samples were then irradiated on
ice with UVB light for 22.5 h.
Polyacrylamide Gel Electrophoresis (PAGE) of Irradiation Products
Analysis of

32

P-end-labeled Tel22 irradiation samples by denaturing PAGE

revealed the presence of two major bands I and II (Figure 3.4A). Band I has the same
mobility as Tel22, whereas band II had increased mobility, suggesting that altered
structures had formed. Most significantly, the rate of formation of band II was greater
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with K+ than with Na+ and is opposite to what had been previously observed for d(T4G4)4
and d(T2G4)4 (19).
Electrospray Ionization-Mass Spectrometry (ESI-MS) of Irradiation Products
For mass spectrometry studies, we submitted nonradiolabeled Tel22 to the same
procedure as described above. The individual bands were visualized by brief exposure to
UVC light and excised from the gel. The products from irradiation in K+ solution for 2 h
were extracted from bands corresponding to I and II, and from the intervening band. ESIMS analysis of these products on a quadrupole time-of-flight (Q-Tof) mass spectrometer
gave a molecular weight of 6,966, as did those from the unirradiated parent ODN,
indicating that they are intramolecular photoproducts.
Nuclease P1 (NP1)-Coupled HPLC Assay of Irradiation Products
NP1 is an endonuclease that degrades photoproduct-containing DNA to smaller
photoproduct-containing fragments that are characteristic of the type of photodamage
(20, 25). NP1 functions by binding to the base portion of a nucleotide after which it
hydrolyzes the phosphodiester bond on the 3'-side to yield a deoxynucleotide with a 3'hydroxyl group (26, 27). Because NP1 does not bind to photodimerized bases, it cannot
cut on the 3'-side of either nucleotide involved in photodimer formation. As a result, NP1
digestion produces trinucleotides, pd(T=TN), from adjacent thymine dimers, and
tetranucleotides, pd[T(N)]=pd[T(N)], from nonadjacent dimers, and mononucleotides,
pdN, from undamaged nucleotides (Figure 3.2B) (17, 20). With our HPLC method,
mononucleotides elute before 20 min, trinucleotides from 20 to 35 min, and
tetranucleotides from 35 to 45 min, as confirmed by ESI-MS analysis of the eluents.
HPLC analysis of the NP1 digestion products of Tel22 irradiated in Na+ solution showed
a sharp peak corresponding to an adjacent dimer and a small broad peak corresponding to
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nonadjacent thymine dimers (Figure 3.5A). Analysis of the irradiation products in the
presence of K+, however, showed numerous additional sharp peaks corresponding to
nonadjacent thymine dimers (Figure 3.5B).
DNA sequences with a folded secondary structure have increased mobility in gel
electrophoresis compared with the unfolded structure (19, 28-30). NP1 digestion and
mass spectral analysis of the faster moving band II corresponding to a species formed in
K+ solution showed tetranucleotides (peaks 7, 8, 9, 10, and 11) as the major products
(Figure 3.4B). The higher mobility also indicates formation of photodimers that crosslink
the DNA into loops, thereby increasing the mobility relative to that of the unmodified
ODN. The NP1 digestion products of the intermediate band contained a mixture of
trinucleotides (peaks 2 and 3) and tetranucleotides (peaks 7, 8, 9, 10, and 11). NP1
digestion and analysis of band I (Figure 3.4B), however, revealed the presence of only
trinucleotides (peaks 2 and 3), indicative of adjacent thymine dimers, which would not be
expected to change the mobility of the oligodeoxynucleotides, as was observed.
Nucleotide Composition of the Trimer and Tetramer NP1 Degradation Products
We separated the NP1 degradation products by HPLC and determined their
nucleotide compositions by ESI-MS and MS/MS analysis. The nucleotides were
identified first by their molecular weight deduced from the MS and second by tandem
mass spectrometry (MS/MS) experiments. For example, those nucleobases that were not
involved in dimer formation were cleaved from the parent ion upon collisional activation.
Thus, HPLC peak 3 was assigned to pd(T=TA) because it gives a molecular ion [M - H]at m/z 938.2 and a characteristic product ion [M - Ade - H]- at m/z 803.1 (Figure 3.6A).
We also detected a small amount of the TA* photoproduct (peak 2) (Figure 3.7B) (31,
32). HPLC peaks 7 and 8 were both assigned as isomeric pd[T(A)]=pd[T(A)] on the basis
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of a molecular ion [M - 2H]2- at m/z 634.3 and characteristic product ions [pdA - H]- at
m/z 330.1 and [M - Ade - 2H]2- at m/z 566.6 (Figure 3.4C). Using similar reasoning, we
assigned HPLC peak 11 to pd[T(T)]=pd[T(A)] (Figure 3.8A). Some peaks appeared to be
contaminated with products from flanking peaks and were assigned to the major
component, whereas others appeared to contain two products (Table 3.1).
Stereochemistry of the Thymine Photodimers
The stereochemistry of the thymine photodimers was assigned by comparing the
base portion of the photoproducts with authentic thymine cyclobutane dimers (17, 33, 34)
(Figure 3.6B). The base portion of the photodimers was obtained by treating the
trinucleotides and tetranucleotides with 70% hydrogen fluoride in pyridine (HF/pyridine)
(Figure 3.2B). HPLC peak 3 was thereby determined to correspond to the cis,syn thymine
photodimer (Figure 3.6 B and C), and peaks 7, 8, 9, 10, and 11 to thymine photodimers of
either cis,anti or trans,anti stereochemistry or both (Figure 3.4D, Figure 3.9B, Figure
3.8B, and Table 3.1). The syn stereochemistry is consistent with photodimer formation
between adjacent thymines, whereas the anti stereochemistry is expected for photodimer
formation between thymines in opposing loops (interstrand-type product) (Figure 3.2B)
(17). More cis,anti and trans,anti products were detected than expected based on their
symmetry properties (one t,a and two c,a for pd[T(A)]=pd[T(A)] suggesting that there
may be additional isomers because of restricted rotation.
Mapping of Thymine Photodimer Sites
Because the ODN sequence is repetitive, it is not possible to identify directly the
specific thymines involved in adjacent and nonadjacent thymine photodimer formation
by analysis of the trinucleotide and tetranucleotide degradation products. To solve this
problem, we labeled the various loops by constructing three telomere sequences Tel22-Un
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(n = 1, 2, and 3), in which the second T in the TTA loop n was replaced with U, which
undergoes the same photodimerization as T but lacks a C5 methyl group (Figure 3.2).
Owing to the substrate specificity of NP1, the second pyrimidine is always retained in the
trimeric digestion products of an adjacent pyrimidine dimer formed within a single loop,
and in the tetrameric digestion products of a photodimer formed between two different
loops. Thus, if a pyrimidine photodimerization takes place within or between a loop
containing a U, the tri- and tetra-nucleotide digestion products will have different HPLC
retention times, and the molecular ions will be 14 u lower than those only involving loops
containing only Ts. Furthermore, analysis of the characteristic product ions in the ESIproduct-ion spectra can establish whether the U is involved in the photodimerization.
Irradiation of Tel22-U2 in K+ followed by NP1 digestion resulted in a nearly
identical set of photoproducts as that from Tel22, with the exception of a photoproduct
(HPLC peak 2-1, Figure 3.5C), which was identified as pd(T=UA) (Figure 3.7A). This
sole U-containing product indicates that the Ts in loop 2 do not photodimerize with Ts in
the other 2 loops. In contrast, irradiation and digestion of both Tel22-U1 and Tel22-U3 led
to HPLC peaks, n-1, n-4, n-6, and n-12 (n=1 and 3, respectively, where n refers to the
loop containing the U) (Figure 3.5 D and E). These peaks corresponded to the same
photoproducts found in Tel22 except that a T was replaced by a U. The results clearly
establish the involvement of loops 1 and 3 in thymine photodimerization, and
furthermore, that both Ts of loop 1 photodimerize preferentially with only the second T
of loop 3. The basis for the latter conclusion is that Tel22-U1 yielded primarily
pd[T1(U)]=pd[T3(A)] and pd[U1(A)]=pd[T3(A)] (Figure 3.10), whereas Tel22-U3 gave
primarily pd[T1(T)]=pd[U3(A)] and pd[T1(A)]=pd[U3(A)] (Figure 3.11). The detailed
assignment of photoproducts of Tel-Un is given in Table 3.2.
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It is noteworthy that we observed a broad HPLC peak in the digestion products of
irradiated Tel22 (peak 5), and the sequences substituted with U (peaks 15, 25, and 35),
whether irradiated in Na+ or K+ solution (Figure 3.5). Analysis of this peak indicates that
it corresponds to a mixture of thymine photodimers between different pairs of loops
(Table 3.2). We speculate that some or all of these photoproducts are not produced from
specific G-quadruplex structures but from a small fraction of nonspecifically folded
isomers that exist in equilibrium with these structures.
Mechanistic Implications.The inefficient formation of anti thymine photodimers
in the Na+ form of Tel22, which has a basket structure with two proximate lateral loops
(8) (Figure 3.1), was unexpected. Even more unexpected was the efficient formation of
anti thymine photodimers between loops 1 and 3 in the K+ form of Tel22, which is
thought to exist primarily in hybrid-1 and/or hybrid-2 conformations that lack proximate
loops (11, 13). These hybrid structures, however, are also thought to be in dynamic
equilibrium with either or both basket and chair conformations (11, 13, 15) that have
proximate lateral loops that could photocrosslink (Figures 3.1 and 3.12). Given that the
basket form which Tel22 adopts in Na+ did not facilitate photocrosslinking between loops
1 and 3, it is unlikely that the basket form in K+ would be any better. It is possible,
however, that interloop photodimer formation would be more favorable in the chair form,
which has an antiparallel arrangement of loops 1 and 3 compared with the parallel
arrangement in the basket form. The higher preference for isomeric pd[T(A)]=pd[T(A)]
products (peaks 7 and 8) (16% yield) over isomeric pd[T(T)]=pd[T(A)] products (6.5%
yield), is in agreement with a report that the Ts and As involved in the chair
conformation can form a T-A-T-A quartet (22).
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Another explanation for the enhanced photocrosslinking in K+ comes from the
recent discovery that the closely related 22-mer human telomeric sequence
d[(GGGTTA)3GGGT] adopts a different basket structure (Form III) with K+ (9) than the
one found with Na+ (8) (Figure 3.12). The Form III basket structure corresponds to the
Na+ basket structure in which the first GGG sequence misaligns to disrupt the first G
quartet and to increase the size of the first loop by one nucleotide. The increased size of
loop 1 in the Form III structure in K+ is expected to better facilitate photodimer formation
between loop 1 and loop 3 than the basket structure formed in Na+. In support of this, the
Oxytricha telomeric sequence d(T4G4)4, which adopts a basket structure with two 4nucleotide loops in Na+ (35), photocrosslinks efficiently between the third T in loop 1
and the third T in loop 3 (19).
A third possibility is that the triplex intermediates involved in interconverting the
various quadruplex structures (11, 23, 36) can themselves facilitate anti thymine dimer
formation, and are more accessible and/or stable in K+ than in Na+. To test whether
triplexes might be involved, we prepared a truncated form of Tel22, Tel19 (Figure 3.2A),
that lacks the first three Gs necessary to complete the fourth strand of the quadruplex and,
thus, limits the structure to intermediate triplex forms. Deleting the 3 Gs or replacing
them with As in Tel22-A3 (Figure 3.2A) resulted in comparable amounts of the same anti
thymine dimers as formed in Tel22 (Figure 3.13 A and B, respectively), except that the
relative yields of isomeric cis,anti and trans,anti pd[T(A)]=pd[T(A)] (peaks 7 and 8)
were greatly diminished. These results show that although formation of anti thymine
photodimers between loops 1 and 3 can presumably proceed through intermediate Gquadruplex-like triplex structures, they are not produced in the same relative yields as
observed for the G-quadruplex form of Tel22.
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To determine whether or not photocrosslinking between loops 1 and 3 could be
suppressed by choosing a sequence known to more greatly favor a hybrid structure, we
investigated the photochemistry of Tel26, d[AAA(GGGTTA)3GGGAA]. This sequence
was found by NMR to initially adopt a mixture of hybrid-1 and -2 structures in K+ that
quantitatively converts to the hybrid-1 structure on incubation (11, 13). Even though the
hybrid-1 structure lacks proximate loops, the overall yield of anti thymine photodimers in
Tel26 was nearly the same as was found for Tel22, except that there was an even greater
preference for trans,anti pd[T(A)]=pd[T(A)] between loops 1 and 3 (peak 8) (Figure
3.13C). These results suggest that the photocrosslinking of G quadruplexes in K+ is
taking place through a highly photoreactive structure other than a triplex, such as the
chair or Form III basket, that is in rapid equilibrium with the hybrid structures, and that
favors the trans,anti dimer between the central Ts of loops 1 and 3.

Conclusion
We have shown that the G-quadruplex form of the human telomere sequence
Tel22 is susceptible to both adjacent and interloop-specific thymine photodimer
formation in the presence of biologically relevant K+. The adjacent thymine photodimer
has the same cis,syn stereochemistry as do the major cyclobutane photodimers induced
by UVB light in duplex DNA. The interloop-specific thymine photodimers, however, are
all of the anti stereochemistry, which is not observed in duplex DNA irradiated under
native conditions (16). Thus, anti thymine dimers, and in particular their pattern of
formation, may represent a unique photochemical signature for the potassium quadruplex
form of the human telomeric sequences studied herein, and possibly for other folded
DNA structures. Extrapolating from these studies of model systems, we suggest that
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human telomeric DNA may also be susceptible to UVB-induced anti thymine photodimer
formation in vivo, in addition to cis,syn dimer formation, causing hitherto unrecognized
effects on the replication and stability of telomere DNA. Formation of a covalently linked
loop of 13-14 nt is also expected to pose a unique challenge to repair systems. It remains
to be seen, however, whether anti thymine photodimers are produced in human telomere
DNA in vivo and if so, how they affect telomere biochemistry. Nuclease P1 coupled LCMS has been used to detect psoralen photocrosslinks in human genomic DNA (37), but
more sensitive 32P-postlabeling assays, or 14C-postlabeling coupled with accelerator mass
spectrometry (38), may be required to detect anti thymine photodimers in telomeres.
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Table 3.1. Stereochemistry, base composition, and loop assignment of the NP1 digestion
products of UV-irradiated Tel22 shown in Figure 3.5.
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Table 3.2. Stereochemistry, composition, and loop assignment of the NP1 digestion
products of Tel22-Un (n=1, 2, 3) in Figure 3.5 C, D, and E. Loop assignment indicated by
the superscripted number.
HPLC Peak

Stereochemistry

Base Composition

1-1, 2-1, 3-1

c,s

T=UA

1-2, 2-2, 3-2*

----

T=AG

1-3, 2-3, 3-3*

c,s

T=TA

1-4

----

U1(A)=T3(A)
U1(A)=T3(T)†

1-5

----

T1(U)=T(A)
U1(A)=T(A)

1-6

----

T1(U)=T3(A)
U1(A)=T3(A)

1-8

----

U1(A)=T3(A)
T1(U)=T3(A)†

1-12

----

U1(A)=T3(A)

2-5

----

T(A)=T2(U)
T(A)=U2(A)
T1(T)=T3(A)
T1(A)=T3(A)

2-7*

c,a

T1(A)=T3(A)

2-8*

t,a

T1(A)=T3(A)

2-9*

c,a

T1(A)=T3(A)

2-10*

c,a; t,a ‡

T1(T)=T3(A)
T1(A)=T3(A)

2-11*

t,a

T1(T)=T3(A)

3-4

----

T1(T)=U3(A)
T1(A)=U3(A)

3-5

----

T(A)=U3(A)
T(A)=T3(U)§

3-6

----

T1(T)=U3(A)
T1(A)=U3(A)

3-8

----

T1(A)=T2(A)
T1(A)=U3(A)¶
T1(A)=T3(U)¶

3-12

----

T1(A)=U3(A)

Loop assignment indicated by the superscripted number.
*Same products as assigned for Tel22 in Table 1.
†Less than 20% estimated from MS peak intensity.
‡Could not be assigned to a specific product.
§Less than 10% estimated from MS peak intensity.
¶Less than 15% estimated from MS peak intensity.
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Figure 3.1. Known basket, hybrid-1, and hybrid-2 triple quartet forms of human
telomeric DNA that could be adopted by Tel22. The numbering system for the bases
starts from 1 in the human telomere sequence d(TTAGGG)n. The loops are numbered
sequentially, and dark and light gray boxes represent syn and anti guanines, respectively.
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Figure 3.2. Telomeric substrates and cyclobutane pyrimidine dimer photoproducts. (A)
Telomeric sequences used in the present work. The superscript n in Un (n = 1, 2, and 3,
respectively) refers to the loop in which the second T was replaced by U. (B) Adjacent
and nonadjacent photoproducts and their nuclease P1 (NP1) digestion products and
HF/pyridine hydrolysis products. R = CH3 for thymine, and R = H for uracil. Trans,syn
and cis,anti pyrimidine dimers exist as enantiomeric pairs.
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Figure 3.3. CD spectra of 50 µM Tel22 G-quadruplexes in 10mM Tris-HCl (pH 7.5) at 4
ºC. (A) Tel22 in 150 mM K+ solution after denaturing and renaturing process. (B) Tel22
in 150 mM Na+ solution after denaturing and renaturing process. (C) CD spectrum of 50
µM Tel26 G-quadruplex at 4 ºC after 24 h.

94

Figure 3.4. Analysis of UVB irradiated telomeric quadruplexes. (A) Tel22 was UVB
irradiated in 150 mM Na+ or K+ solution at pH 7.5 for the number of hours indicated in
the lane headings, 32P-end-labeled, and then subjected to 15% denaturing PAGE. Bands I
and II and the intervening band were excised and subjected to NP1 digestion. (B) NP1coupled HPLC assay of nonradiolabeled samples corresponding to bands I, II, and the
intervening band. HPLC peaks a and b were not observed in nonelectrophoresed samples
and could not be assigned. Products were detected at 260 nm where the nondimerized
bases have their maximum absorption. (C) Mass spectra and product-ion mass spectra of
the major nonadjacent photoproduct HPLC peak 8. The observation of [pdA - H]- and [M
- Ade - 2H]2- indicate that adenine is the nonphotodimerized base. (D) HPLC assay of
HF/pyridine hydrolysis products of HPLC peak 8 that was contaminated with adjacent
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peaks. The hydrolysis products were detected at 205 nm where the photodimers have
their maximum absorbance, and their stereochemistry assigned by correlation with
authentic thymine photodimers (Figure. 3.6B). The small thymine peak may be caused by
the decomposition of thymine anti dimers in the course of hydrolysis (17). Analysis of
various HPLC fractions established peak 8 to be the trans,anti photodimer.
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Figure 3.5. NP1-coupled HPLC assay of Tel22 and the U-substituted sequences after 2.5
h UVB irradiation at pH 7.5. (A) Tel22 in 150 mM Na+ solution. (B) Tel22 in 150 mM
K+ solution. (CE) Tel22-Un in 150 mM K+ solution. The HPLC peaks are labeled n-m, in
which n refers to the loop that is substituted by U, and m refers to the order of elution.
Peak c could not be assigned. Peaks 1-3 are trinucleotides resulting from adjacent
photoproducts, and peaks 4-12 are tetranucleotides resulting from nonadjacent
photoproducts.
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Figure 3.6. ESI-MS/MS and HF/pyridine hydrolysis assay of HPLC peak 3. (A) ESIMS/MS of peak 3, (B) HPLC of authentic thymine cyclobutane dimers, and (C)
HF/pyridine hydrolysis-coupled HPLC assay of peak 3.
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Figure 3.7. ESI-MS/MS of (A) HPLC peak n-1 (n = 1, 2, and 3), pd[T=UA] and (B)
HPLC peak n -2 (n = 1, 2, and 3), pd[T=AG] corresponding to the TA* photoproduct.
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Figure 3.8. ESI-MS, ESI-MS/MS, and HF/pyridine hydrolysis-coupled HPLC assay of
HPLC peak 11. (A) ESI-MS and MS/MS. (B) HF/pyridine hydrolysis-coupled HPLC.
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Figure 3.9. ESI-MS, ESI-MS/MS, and HF/pyridine hydrolysis-coupled HPLC assay of
HPLC peak 9. (A) ESI-MS and MS/MS. (B) HF/pyridine hydrolysis-coupled HPLC
assay.
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Figure 3.10. ESI-MS and ESI-MS/MS of HPLC peak 1-6.
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Figure 3.11. ESI-MS and ESI-MS/MS of HPLC peak 3-6.
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Figure 3.12. Photodimer sites mapped onto chair and Form III G-quadruplex forms of
Tel22 and onto triplex intermediates possibly involved in equilibrating between these and
other structures. Solid double lines indicate sites of observed anti thymine photodimer
formation between loops 1 and 3.
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Figure 3.13. NP1-coupled HPLC assay of UV-irradiated Tel19, Tel 22-A3, and Tel26.
(A) Tel19 in K+ solution after 2.5 h UVB irradiation. (B) Tel 22-A3 in K+ solution after
2.5 h UVB irradiation. (C) NP1-coupled HPLC assay of Tel26 in K+ solution (see Figure
3.3) after 2.5 h UVB irradiation. Anti dimers of Tel26 were mapped to loops 1 and 3 by
replacement with U.
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Chapter 4

m

CA*: A New Photoproduct of 5' -

Methylcytosine and Adenine Characterized
by HPLC and Mass Spectrometry
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Abstract
The UV portion of sunlight is mutagenic and can modify DNA by producing
various photoproducts.
cyclobutane,

UV photodamage often occurs at dipyrimidine sites, to give

pyrimidine-(6-4)-pyrimidone

(6-4),

and

pyrimidine-(6-4)-Dewar

pyrimidone (Dewar) photoproducts, and at TA and AA sites. There is no reported
evidence, however, of UV-photoproduct formation between C or 5-methylC (mC) and A.
Irradiation of d(GTATmCATGAGGTGC) with UVB light at physiological pH gives an
unexpected photoproduct that undergoes fast thermal deamination but does not revert to
its original structure under UVC irradiation. Evidence from nuclease P1 (NP1) digestion
coupled with electrospray ionization (ESI)-MS/MS is in accord with product formation
between

m

C and A.

HPLC analysis indicates that deamination gives a T<>A

photoproduct that coelutes on reverse-phase chromatography with the well-known TA*
photoproduct, formed from an initial [2+2] reaction between C5-C6 and C6-C5 of the
adjacent thymine and adenine (as shown by Zhao, X., et al. (1996) Nucleic Acids Res. 24,
1554-1560 and

Davies, R. J. et al. (2007) Nucleic Acids Res. 35, 1048-1053).

Furthermore, the deamination product of the unknown mC<>A photoproduct and the TA*
photoproduct undergo nearly identical fragmentation in tandem MS. The evidence, taken
together, indicates that the deamination product of the unknown mCA photoproduct has
the same chemical structure as the TA* photoproduct. Therefore, the unknown
photoproduct is referred to mCA* photoproduct, which, upon deamination, gives the TA*
photoproduct.
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Introduction
Sunlight-induced DNA photo damage is one cause of mutations leading to skin
cancer. The toxic, mutagenic and carcinogenic effects of sunlight, however, have been
principally attributed to the ultraviolet (UV) portion, which can produce a variety of
photoproducts in DNA (1-5). If not repaired, these lesions lead to mutations, increasing
the risk for cancer. Until now, the most prevalent UV photoproducts are found at
pyrimidine sites, giving cyclobutane dimers, cyclobutane, pyrimidine-(6-4)-pyrimidone
(6-4)1, and their pyrimidine-(6-4)-Dewar pyrimidone (Dewar) valence isomers (6-10).
Other UV photoproducts containing adenine such as TA*, which forms from an initial
[2+2] cycloaddition reaction between C5-C6 and C6-C5 of the adjacent thymine and
adenine (11, 12), A=A and AA* (13-16) are also well known. No UV photoproduct
formation between other pairs of bases, however, has been reported.
Mutations due to UV irradiation are predominantly C-to-T transition and CC-toTT tandem transitions at a dipyrimidine sequence (17, 18).

Most C-to-T mutation

hotspots occur at methylated CpG sites (19-21). The most common hypothesis is that the
C-to-T transition occurs after the deamination of C or 5-methylC (mC), leading to
insertion of A instead of a G in the next replication cycle (22).

The important

deamination reaction of mC-containing photoproducts is affected by flanking bases, pH,
and secondary structure (23).
In the course of synthesizing TmC photoproducts of d(GTATmCATGAGGTGC)
produced by irradiation with biologically relevant UVB (290-320 nm) light for
deamination studies (Scheme 4.1), we found an unknown photoproduct. To elucidate the
structure of the unknown, we employed enzyme digestion, correlation of HPLC retention
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times of unknown and reference materials, and mass spectrometry (MS). The combined
approach allowed us to identify the unknown as a mCA* photoproduct (photoproduct
formed between 5-methylcytosine and adenine that deaminates to give the TA* product),
the name of which indicates covalent linkages between C5-C6 and C6-C5 of mC and A as
in TA*. The identification took advantage of its rapid deamination to afford the wellknown TA* photoproduct (11, 12, 16, 24, 25). In this chapter, we describe the structural
determination of this unusual and first known photoproduct between mC and A.

Materials and Methods
Materials
Oligodeoxynucleotides

(ODNs)

were

Technologies, Inc. (IDT) (Coralville, Iowa).

purchased

from

Integrated

DNA

Nuclease P1 (NP1) from Penicillium

citrinum was from Sigma (St. Louis, MO). Milli-Q (18.2 mΩ/ cm) water was prepared
by using a Millipore Corporation (Billerica, MA) Milli-Q water purification system.
HPLC solvents were from Fisher Scientific (Fair Lawn, NJ).
Instrumentation
UVB irradiation was carried out with a 302 nm transilluminator (Spectroline
model TR-302) or a 312 nm lamp with two Spectroline® XX-15B UV 15-watt tubes
(peak UV intensity of 1,150 µW/cm² at 25 cm from the source) from Spectronics
Corporation (Westbury, New York). UVC (100-290 nm) irradiation was with a model
UVG-254 Mineralight lamp (254 nm, Ultra-Violet Products, Inc., San Gabriel, CA).
HPLC separation and analysis were carried out with a System Gold HPLC BioEssential
HPLC with binary gradient 125 pumps and a diode array Model 168 detector (Beckman
Coulter, Inc., Fullerton, CA). An X-Bridge column (C18, 4.6 ×75 mm, 2.5 μm, 135 Ǻ)
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from Waters Corporation (Milford, MA) was used for reversed-phase HPLC (RP-HPLC).
Mass spectra were obtained with a Thermo Finnigan LTQ-FT mass spectrometer
(Thermo Fisher Scientific, Inc., Waltham, MA) or an Applied Biosystems 4700 tandem
time-of-flight mass spectrometer (Applied Biosystems, Foster City, CA).
UV Irradiation of ODNs
ODNs from IDT were used without further purification. ODN solutions for UV
irradiation were prepared as 50 PM in 10 mM tris(hydroxymethyl)aminomethane HCl
(pH 7.6). Samples were then purged with nitrogen gas for 5 min and placed in a
polyethylene Ziplock bag. For 302 nm irradiation, the bags were placed on the
transilluminator and irradiated for 2.5 h in a cold room (4 ºC). For the 312 nm and UVC
irradiations, the bags were placed on ice and irradiated for 2.5 h at a distance of
approximately 1 cm from the lamp. All samples from irradiation were immediately
transferred to Eppendorf tubes and stored in a -80 ºC freezer to prevent deamination.
RP-HPLC Analysis and Purification of Products
Basic solvents were used for HPLC to prevent any mC-containing photoproducts
from deamination during separation. The flow rate was 1 mL/min with a gradient of 020% solvent B in solvent A for 50 min (solvent A: 50 mM triethylammonium acetate, pH
7.8; solvent B: 50% acetonitrile in 50 mM triethylammonium acetate, pH 7.8). Elutes
were immediately put on dry ice and then stored in a -80 ºC freezer until MS analyses
could be conducted.
NP1 Digestion
Separated photoproducts were collected accompanying the HPLC separation, put
on dry ice, and then stored in a -80 ºC freezer. HPLC fractions were thawed on ice
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before digestion. A 2-5 µL aliquot was mixed with 0.5 µL, 1 unit/µL NP1 and digested
on ice for 3-5 min. The digested samples were then submitted to MS analysis.
MS Analysis
Electrospray ionization (ESI) mass spectra were obtained in the negative-ion
mode on a LTQ-FTICR instrument. Typically, samples were introduced to the mass
spectrometer by injecting in a 10 µL loop. A solution of 50/50 (v/v) methanol/water was
used as the spray solvent at a flow rate of 5 µL /min. The spray voltage was 3.5 kV. The
capillary voltage and temperature were 46 V and 250 ºC, respectively. ESI-MS/MS
experiments were done by using collision-activated dissociation with helium as the
collision gas. The mass window for precursor-ion selection was 2.5 m/z units, and the
collision energy was 30% of the maximum value, producing product ions of good signalto-noise ratio. Exonuclease digestion coupled MALDI-MS experiments were done on the
4700 MALDI TOF/TOF instrument by using the procedures previously reported (26).

Results and Discussion
HPLC Analysis of the New Photoproduct
After irradiation of d(GTATmCATGAGGTGC) with 302 nm light, RP-HPLC
analysis showed four significant photoproducts (PPs): PP1 (~ 18% yield based on HPLC
peak areas), PP2, PP3, and PP4 (Figure 4.1A, upper panel).

After incubating the

irradiation mixture in a 37 ºC water bath for 1 h to cause deamination, we found that the
peaks corresponding to PP1 and PP2 decreased, whereas two new peaks, labeled as PP1*
and PP2* increased (Figure 4.1A, lower panel). PP1 deaminates faster than PP2 judging
from HPLC peak areas: approximately 60% of PP1 had deaminated whereas only 30%
of PP2 had done so. These new peaks may correspond to deamination products of mC
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photoproducts. When 312 nm light was used, we saw only two significant photoproducts
PP1 (~ 22% yield based on HPLC peak areas) and PP4 in the HPLC analysis (Figure
4.1B, upper panel). Thermal incubation of the irradiation mixture, as described above,
caused the peak corresponding to PP1 to decrease and to be replaced by a new peak
labeled as PP1* (Figure 4.1B, lower panel).

The sum of peak areas corresponding to

PP1 and PP1* is roughly that of the original peak PP1, an observation that is consistent
with the assignment that PP1* corresponds to deamination of an mC photoproduct in PP1.
Furthermore, PP2* is likely to be the deamination product of PP2, which is also an mCcontaining photoproduct.
NP1-coupled ESI-MS and ESI-MS/MS Assay
When we treated the photodamaged ODN with nuclease P1, we found a
trinucleotide triphosphate, which upon mass spectrometric analysis, gave ions of m/z of
937 for PP1, PP2, PP3 and PP4, and of m/z 938 for PP1* and PP2*. These are the
expected digestion products of an ODN containing a photoproduct between adjoining
bases (27, 28). The trinucleotide that gives an ion of m/z 937 has a composition of
[pd(T<>mCA) - H]- or [pd(mC<>AT) - H]-, and the one of m/z 938 is either [pd(T<>TA) H]- or [pd(T<>AT) - H]-.

To resolve these possibilities, we carried out MS/MS

experiments on selected ions of the tri-nucleotides released from the ODN photoproducts
in which only the non-damaged base can be lost while the photochemically coupled bases
cannot be fragmented. We found the most abundant product ions of m/z 615 and 616 for
PP1 and PP1*, respectively, both of which were formed by loss of a 2’-deoxythymidine5’-phosphate (pdT) (Figure 4.2).

These observations allow us to propose that the

trinucleotides formed in NP1 digestion of PP1 and PP1* are pd(mC<>AT) and
pd(T<>AT), respectively; the latter is a deamination product of the former.
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We also observed that the most abundant fragment ions are of m/z of 802 and 803
for PP2, PP2*, respectively; these arise from a loss of 2’-deoxyadenosine-5’-phosphate
(pdA) (Figure 4.3). We can now propose that the trinucleotides from PP2 and PP2* are
pd(T<>mCA) and pd(T<>TA), respectively; the latter is a deamination product of the
former. Similarly, we found that the most abundant product ions are of m/z of 802 for the
digestion products of PP3 (Figure 4.4) and PP4 (Figure 4.5), arising from losses of pdA.
The trinucleotides liberated in the digestion of PP3 and PP4 are both assigned as
pd(T<>mCA), because they can only lose a pdA species.
Stereochemistry of PP2, PP3 and PP4
Given that PP1 and PP2 deaminate, they may be cyclobutane photoproducts (6,
29, 30). It is known that UVC light can revert [2 + 2] cyclobutane photoproducts to their
parent ODNs and convert Dewar photoproducts to their (6-4) valence isomers, which are
detectable at 325 nm.
photoproducts.

Deamination does not change the stereochemistry of the

We carried out UVC irradiation with 254 nm light on the HPLC-

separated PP1*, PP2*, PP3 and PP4. Given that no photoreversion or photoconversion of
PP1* occurred, we can exclude PP1 and PP1* as cyclobutane photoproducts. PP2* and
PP3, however, reverted to the parent ODN, indicating that they are cyclobutane
photoproducts of cis-syn (c,s) or trans-syn (t,s) stereochemistry. We assigned PP2 and
PP2* as mC-containing (c,s) photoproduct because PP2 deaminates rapidly. We assigned
PP3 as a

m

C-containing (t,s) photoproduct because it undergoes no significant

deamination under the conditions used here, as would be expected on the basis of
previous work (6, 10, 29). PP4 undergoes a transition to its (6-4) isomer, suggesting a
Dewar photoproduct (Table 4.1).
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Comparison of PP1* and the authentic TA* Photoproduct by HPLC and NP1-coupled
ESI-MSn
Considering that PP1 is an mC<>A photoproduct and that it may also contribute to
m

C to T mutations via deamination, we were motivated to determine its structure.

Interestingly, PP1 deaminates even faster than the T[c,s]mC photoproduct. Given that
deamination doesn’t change the stereochemistry of a photoproduct, we decided to
investigate PP1*, the thermally stable deamination product of PP1. Further, given that
the deamination product PP1* contains a T<>A photoproduct but is not a cyclobutane
adduct, we suspected that it has the structure of the well known TA* photoproduct (11,
12). Thus, we compared the RP-HPLC retention time of the T<>A photoproduct formed
from deamination of PP1* to that of the authentic TA* photoproduct formed within the
same sequence context.
The authentic TA* photoproduct was obtained by UVC (254 nm) of
d(GTATTATGAGGTGC). We assigned the reference photoproducts on the basis of
photoconversion, photoreversion, and NP1-coupled ESI-MS/MS as described above
(Figure 4.6). Particularly, we can distinguish T5A6* from T2A3* with bovine spleen
phosphodiesterase-coupled ladder sequencing by MALDI-MS (data not shown) (26, 31,
32), taking advantage of exonuclease digestion that goes from 5′ to 3′ and terminates just
before T5. The approach was to inject onto the HPLC the same amount of sample
individually and then to co-inject them. Co-elution of PP1* and the T5A6*-containing
photoproduct 14-mer strongly suggests that the two photoproducts have the same
structure (Figure 4.6). This suggestion was then confirmed by NP1-coupled ESI-MSn
analysis, whereby both MS2 and MS3 of the NP1 digested PP1* and authentic T5<>A6
photoproduct 14-mer show the same fragmentation pattern (Figure 4.7).
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As shown in the product-ion spectra, both compounds undergo the expected major
neutral loss of pdT yielding a most abundant product ion of m/z 616. An MS3 experiment
shows that the m/z 616 ion formed from the precursor ion gives the same major product
ion of m/z 438. The fragmentation to give the m/z 438 ion is a loss of the 2-deoxyribose
ring with the attached phosphate group (pdF). The other distinctive product ion is of m/z
314, which is most abundant in an MS4 experiment whereby the m/z 438 ion is probed as
formed by the sequence m/z 938 Æ m/z 616 ion Æ m/z 438 ion. The ion of m/z 314
likely arises by the loss of phosphoric acid (H3PO4), possibly via an ion-dipole complex,
accompanied by the elimination of acetylene (C2H2). These fragments are consistent with
a photoproduct structure made up of a stable tricyclic center that loses groups on the
periphery.

More importantly, they add support that the newly discovered

m

C<>A

photoproduct is an analog of the well-known TA* photoproduct (Scheme 4.2).

Conclusion
We discovered a new photoproduct of d(GTATmCATGAGGTGC) involving
reaction of mC and A. Deamination gave the well-known TA* photoproduct (11, 12, 16,
24, 25) whose structure was previously completely established by NMR (11), MS (16),
and X-ray crystallography (12), and its mutation spectrum determined in bacteria (33).
Comparisons of HPLC retention times and tandem MS show that the properties of the
m

C<>A deamination product are nearly identical to those of the authentic TA*

photoproduct, substantiating their identical structures. Interestingly, TA* forms under
UVC whereas mCA arises under UVB. This is consistent with the UV absorbance of
thymine (λmax = 267 nm), which has greater overlap with UVC whereas mC (λmax = 278
nm) has greater overlap with the UVB lamp.

115

The mC residues in DNA play an important role in regulation of gene expression
and chromatin structure (34, 35), and UV-induced damage of mC could be mutagenic.
Although methylation of C predominantly occurs at d(CpG) sites in mammals (35, 36), it
is conceivable that an inter-strand type mCA* could form in DNA that is folded to bring
m

C and A proximate to each other (26, 37-39). Non-CG methylation is present primarily

in viral or stably integrated plasmid DNA sequences (40) and has also been detected in
significant abundance in human embryonic stem cells and induced pluripotent stem cells
(41, 42), although photochemical damage should not be an issue for them, and as well as
in plants (43-45). Further photochemistry studies could be conducted targeting a series of
DNA duplexes containing a

m

CA site and folded DNA having

m

C and A in close

proximity to explore the possibility of intra-and inter-strand type
respectively.

m

CA* formation,

Future studies will also required to define better the biological

consequences of mCA* photoproduct formation.
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Table 4.1. Identification of UVB induced photoproducts of d(GTATmCATGAGGTGC)
at pH 7.6.
Photoproduct (PP)
Photodimer Assignment

PP1
m

CA*

PP1*

PP2

PP2*

PP3

PP4

TA*

T[c,s]mC
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Figure 4.1. RP-HPLC of UVB-induced photoproducts of d(GTATmCATGAGGTGC) at
pH 7.6 (upper panel) and of corresponding deamination products (lower panel) with A)
302 nm light and B) 312 nm light. SM: starting material; The designation * is used in
this context for a photoproduct that has undergone deamination.
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Figure 4.2. Product-ion spectra of the trinucleotides of NP1 digested photoproducts PP1
(A) and PP1* (B), indicating a mC<>A and T<>A photoproduct, respectively.
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Figure 4.3. Product-ion spectra of the trinuclteotides of NP1 digested photoproducts PP2
(A) and PP2* (B), indicating a T<>mC and T<>T photoproduct, respectively.
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Figure 4.4. Product-ion spectrum of the trinucleotide of NP1 digested photoproduct PP3,
indicating a T<>mC photoproduct.
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d(GTATTATGAGGTGC), B) ~ 360 pmol of deamination product of HPLC fraction of
d(GTATmCATGAGGTGC),
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contamination peak of PP3 from HPLC separation (Figure 4.1A, lower panel)
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Chapter 5

A Mass Spectrometric Investigation of the
Interaction of hApe1 with the Redox Activity
Inhibitor, E3330
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Abstract
Human apurinic/apyrimidinic endonuclease 1 (hApe1) is a multi-functional
protein having two major functions: apurinic/apyrimidinic endonuclease activity for
DNA damage repair and redox activity for gene regulation. It was reported that Ape1
reduces a number of important transcription factors that are involved in cancer promotion
and progression. The underlying redox mechanism, however, is not yet clear. The crystal
structure of hApe1 indicates there are seven cysteines (C65, C93, C99, C138, C208,
C296, and C310), among which C99 and C138 are solvent-accessible and C65, C93, and
C99 are located in the redox domain. It was hypothesized that one or more cysteines are
involved in the redox fuction. A further hypotheis is that hApe1 reduces the down-stream
transcription factors via a thiol/disulfide exchange mechanism. E3330, (2E)-3-[5-(2,3dimethoxy-o-methyl-1,4-benzoquinoyl)]-2-nonyl-2-propenoic acid, is a specific inhibitor
for the the redox function of hApe1. The interaction mechanism is not known although a
binding constant of 1.6 nM was determined by SPR, indicating a specific and strong
interaction between hApe1 and E3330. In our study, hydrogen/deuterium exchange
(HDX) experiments show no difference between Ape'40 (a truncated form of hApe1
with residues 40-318) without (apo) and with E3330 (holo) forms, suggesting there is no
siginificant interaction between Ape'40 and E3330. ESI and nESI-MS analysis indicates
that no strongly bound complex formed between Ape'40 and E33330 can be introduced
to the gas phase. Taken together, there is no evidence for a strong interaction between
Ape'40 and E3330. In the presence of N-ethylmaleimide (NEM), a “+ 7 NEM” adduct
was seen for Ape'40 with E3330, suggesting that a locally unfolded form coexists with
the folded form in an equilibrium that is driven by irreversible NEM labeling. E3330
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interacts with and stabilizes this locally unfolded form. Trypsin digestion coupled LCMS/MS analysis shows there are up to 8% of disulfide bonds induced by E3330 among
the cysteines in the redox domain, which are far apart from each other in the folded form,
as indicated by the X-ray crystal structures. We also propose that the locally unfolded
form interacts with E3330 and allows disulfide bonds to form in the redox domain. The
locally unfolded form is thereby proposed to be the potential redox-active form.
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Introduction
Human apurinic/apyrimidinic endonuclease 1 (hApe1) is a multi-functional
nuclear protein (1-7). It has two major functions: DNA damage repair via its
apurinic/apyrimidinic endonuclease activity and activation of down-stream transcription
factors to bind DNA via its redox activity. Ape1 was first identified and characterized as
a nuclear factor, termed as a redox effector factor-1 (Ref-1) (8, 9), and later identified as
Ape1 (10). Ape1 reduces a number of important transcription factors including AP-1,
P53, NF-κB, HIF-1α, and TTF, thus stimulating their DNA binding activity for gene
regulation (10-20). Ape1 also participates in the base excision repair (BER) pathway by
cleaving the 5' phosphodiester bond of an abasic site, which is generated by DNA
glycosylases that excise a base damaged by alkylation or oxidation, and leaving a 3'-OH
and 5'-deoxyribose phosphate (21-23). The two functional domains of the protein are
separable: DNA repair activity is located in the C-terminal, and redox activity in the Nterminal regions (24-28). Although the mechanism whereby Ape1 repairs DNA is
relatively clear, the mechanism of its redox activity is poorly understood.
Based on the crystal structure (Figure 5.1), C99 and C138, among the seven
constituent cysteines (C65, C93, C99, C138, C208, C296, and C310), are solventaccessible (28-31). There are three cysteines (C65, C93, C99) located in the redox
domain and buried in the core of the protein; C65 and C93 are positioned on opposite
sides of the beta sheet. There are no disulfide bonds according to the X-ray crystal
structure. The sulfur atoms of the two closest cysteine residues, C93 and C208, are
approximately 3.5 Å apart, which is longer than the length of a typical disulfide bond (2.2
Å). It has been hypothesized that one or more cysteines in the redox domain are involved
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in the redox function of hApe1. Most previous reports suggest that C65, a residue unique
to mammalian sequences, is essential for the redox activity (24, 31) with one exception
that claims Cys 65 is not required (32). In a study employing both site-directed
mutagenesis and in vitro electrophoretic-mobility-shift-assay (EMSA) analysis, each of
the seven cysteines in hApe1 was substituted one at a time with Ala. Only hApe1 C65A
was redox inactive when reduced, and only hApe1 C93A remains redox active when
oxidized (24), suggesting that the redox mechanism involves a disulfide bond between
C65 and C93. Although the crystal structure shows that C65 is inaccessible to solvent, it
is possible that Ape1 can change its conformation to expose C65 so it can react with the
target cysteines upon interacting with the down-stream transcription factors.

These

factors, however, do not share a common structural motif for binding hApe1 (31).
hApe1 levels are elevated in some cancers (e.g., ovarian, cervical, and germ cell
tumors) and typically associated with aggressive proliferation and enhanced resistance to
therapeutic agents (33-36). Recently, a novel approach to cancer therapeutic agents
targeted the redox activity of hApe1 (7, 37). A quinone derivative E3330, (2E)-3-[5-(2,3dimethoxy-o-methyl-1,4-benzoquinoyl)]-2-nonyl-2-propenoic acid, was found to inhibit
specifically the redox ability of hApe1 (38-41). E3330 is able to kill a variety of cancer
(i.e., ovarian, colon, lung, breast, brain, pancreatic, prostate, multiple myeloma) cells but
does not significantly affect normal cells (42). An earlier study with surface plasmon
resonance (SPR) reported that the binding constant for hApe1 and E3330 is 1.6 nM,
which indicates strong and specific binding between hApe1 and E3330 (38). No further
studies have been carried on the interaction between hApe1 and E3330 to probe, for
example, the location of the binding site and the conformational changes, if any,
associated with hApe1 binding to E3330.
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We report herein an investigation of the interaction of
Ape'40, a truncated form of hApe1 (residues 40-318) (Figure
5.2), and E3330 by using amide hydrogen/deuterium exchange
(HDX) and N-ethylmaleimide (NEM) (see NEM structure)

O
O
O

O

labeling coupled with MS analysis. At the time of this study,

O

OH

E3330

Ape'40 was more available, and we were able to conduct a complete set of experiments
on this protein. Nevertheless, Ape'40 is a suitable model because truncations of up to 40
CH3

residues on the N-terminus do not affect the redox or DNA repair
O

activity of hApe1 (24, 25). HDX and mass spectrometry (MS)

N

O

combine as a powerful approach for probing protein structure,
RS

dynamics, and interactions with ligands. It examines changes in H-

NEM

bonding at all amide sites, except that of proline (43-52). Furthermore, HDX coupled
with a titration strategy should verify the high binding affinity of hApe1 and E3330 by
using PLIMSTEX (protein-ligand interactions by MS titration and HD exchange) (5356). A complementary approach for determining protein conformational change is amino
acid-specific covalent labeling (57-59). NEM is a water-soluble, small molecule that
specifically reacts with solvent-accessible cysteines via a Michael addition. This reagent
is widely used in protein footprinting (60-65). A combination of both footprinting
strategies should allow a more complete picture of this protein/ligand binding to be
elucidated.

Material and Methods
Materials
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Ape'40 was expressed and purified in the Georgiadis lab as pervious described
(66). The stock solution contained 2.5 mM protein in 10 mM

O
CO 2H

HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) (pH =
7.5) buffer.

E3330 and its analog compound 8-51, (E)-3-(3-

methoxy-1,4-naphthoquinon-2-yl)-2-methylpropenoic

acid,

were

O Me
O

SR

8-51

synthesized by Rod Nyland in the Rick Borch Laboratory (Department of Medicinal
Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 479074)
as previously described (67, 68). The stock solution contained 100 mM E3330 in DMSO.
Both Ape'40 and E3330 were stored in a -80 rC freezer until used.
HDX and Electrospray Ionization Mass Spectrometry (ESI-MS) Experiments of Ape'40
without and with E3330
HDX kinetics experiments were conducted with Ape'40 without (apo) and with
E3330 (holo). Both apo and holo solutions were prepared by incubating the protein, with
or without E3330, in 10 mM HEPES (pH = 7.5) and 150 mM KCl at 25 rC. For the apo
form, Ape'40 was incubated for 1 h. For the holo from, Ape'40 and E3330 were
incubated at a molar ratio of 1:10 for 1 h. HDX experiments were carried out at 25 rC in
a 90% D2O buffer with 10 mM HEPES (pH = 7.5) and 150 mM KCl. At certain times (0,
0.5, 1, 2, 4, 8, 15, 30, 60, 120, 180, and 240 min), a 10 PL of HDX solution was
quenched with cold 1 M HCl to decrease the pH to 2.5. The quenched solution was
loaded onto an Opti-Guard C18 column (10 mm x 1 mm i.d., P.J. Cobert Associates, St.
Louis, MO) by using a six-port Rheodyne 7725 manual sample injector (P.J. Cobert
Associates, St. Louis, MO). The C18 column was pre-equilibrated with 0.1% formic acid
(FA) aqueous solution. To minimize back exchange of the D label at the backbone amide
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positions, the injector, the Opti-Guard® 1 mm C18 column, and all transfer silica tubing
were placed in an ice-bath. The protein was back-exchanged and desalted with ice-cold
0.1% FA solution and eluted with 50% ACN with 0.1% FA at a flow rate of 30 µL/min.
All samples were analyzed by ESI-MS on a Micromass Q-TOF UltimaTM
GLOBAL equipped with a Waters CapLC system and a Z-spray ESI source operated in
the positive-ion mode. The capillary voltage was 3.0 kV, collision energy was 10 eV,
and the source and desolvation temperatures were 80 rC and 150 rC, respectively. All
mass spectra were deconvoluted by MaxEnt1 algorithm with MassLynx 4.0, which are
part of the software of this system.
All modeling and curve fitting were done by using Mathcad 2001 Professional
(Mathsoft, Inc., Cambridge, MA) and a custom-built program (69).
NanoESI (nESI) MS
Ape'40 was incubated in 1 M ammonium acetate (pH 7.5) with or without E3330
at room temperature (RT) for 4 h.

Protein samples were analyzed by nESI-MS in the

positive-ion mode on a Bruker MaXis UHR-TOF (ultra-high resolution time-of-flight) at
a flow rate of 25 nL/min. The capillary voltage was set at -1000-1200 V. Dry gas and
temperature were at 5.0 L/min and 50 °C, respectively. The instrument was externally
calibrated by using “Tuning Mix” (Agilent Technologies). The spray tips were made inhouse by pulling a 150 µm i.d. × 365 µm o.d. fused silica capillary with a P-2000 laser
puller (Sutter Instrument Co., Novato, CA). A four-step program was used with the
parameter setup as follows with all other values set to zero: Heat = 290, velocity = 40,
delay = 200; Heat = 280, velocity = 30, delay = 200; Heat = 270, velocity = 25, delay =
200; Heat = 260, velocity = 20, delay = 200. Tips were cut accordingly to allow a good
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spray under the experimental conditions. For each sample, a new tip was used to avoid
cross contamination.
Covalent Labeling and ESI-MS
For compound 8-51 labeling, Ape'40 and its mutants (C99A, C138A,
C99/C138A), where either or both C99 and C138 were replaced by alanines, were
incubated with compound 8-51 in 10 mM HEPES (pH = 7.5) at RT ([protein] = 100 µM;
[8-51] = 500 µM). After 4 h, the reactions were quenched by adding 10 µL of 20 mM
dithiothreitol (DTT) to 10 µL of the above solution. The DTT-quenched samples were
diluted with water before MS analysis. Typically, a solution containing 5 pmol protein
was loaded to a C18 column, desalted with water, and then eluted to the Bruker MaXis
UHR-TOF instrument with 50% ACN with 0.1% FA at 10 µL/min. The capillary voltage
was -3600 V. The nebulizer pressure was 0.4 bar, and the drying gas flow was at 1.0
L/min at a temperature of 180 °C. Deconvolution was done with the MaxEnt1 algorithm
supplied by the manufacturer of the mass spectrometer system.
For NEM labeling, 10-20 µL of Ape'40/NEM (Ape'40:NEM = 1:5, mol/mol)
and Ape'40/NEM/E3330 (Ape'40:NEM:E3330 = 1:5:5, mol/mol/mol) Ape'40 samples
were incubated in 10 mM HEPES buffer (pH 7.5) at RT; the protein concentration was
100 µM. At a certain time, a 1 µL aliquot was removed and quenched with 1 µL of 20
mM DTT. Mass spectra were collected on the Bruker MaXis UHR-TOF or Waters
Micromass Q-TOF instrument as described above.
Data Processing of NEM-Labeling
A number of the equation parameters were extracted from the kinetic data by
nonlinear least squares fitting of theoretical signals, computed from the parameter
dependent system state trajectories, to experiment data. The system state was a vector
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that has the solution chemical species concentrations as the vector coordinates. In each
trial of the search, the postulated parameters together with the system state of
concentrations permitted the calculation of the time rate of change of the state by
computing the fluxes into and out of each species as described by the system equations.
This process implemented a vector first-order ordinary differential equation, which was
solved by numerical integration for the time interval of reaction initiation to the longest
reaction time to give the state time trajectory in each fitting trial. For comparison with
the experiment data, the theoretical signal for each Ape species was computed as a
fraction of all Ape species concentrations that were first weighted by a relative sensitivity
factor that varied linearly with slope gN with the number of NEMs attached starting with
one for ApeΔ40 by itself. The calculations were carried out in the computer application
Mathcad 14.0 M010 (Parametric Technology Corporation, Needham, MA 02494 USA).
The numerical integration of the differential equation was carried out by the adaptive
fourth-order Runge-Kutta function “Rkadapt”.
HDX and Electrospray Ionization Mass Spectrometry (ESI-MS) Experiments of the NEM
adducts of Ape'40
A 30 µL solution of ApeΔ40/E3330/NEM was incubated with 10 mM HEPES
(pH 7.5) for 22 h at RT ([protein] = 100 µM; [E3330] = [NEM] = 500 µM). To quench
the NEM labeling reaction, 0.5 µL of 1 M DTT was added to the above solution. An
aliquot of the 2.8 µL DTT quenched solution was diluted to a final 40 µL of 93% D2O
medium with 10 mM HEPES (pH 7.5) and 150 mM KCl and incubated for various times
to obtain the HDX kinetics at 25 °C. The HDX reaction was quenched by adding 1 µL of
1 M cold HCl. ESI-MS and data processing was the same as described above.
LC-MS/MS Assay of Disulfide Bond Formation
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A 200 µL solution of Ape'40 (10 µM) and E3330 (50 µM) was incubated in 10
mM HEPES (pH = 7.5) at 37 °C for 1 h. NEM was then added to block any unreacted
Cys and prevent disulfide-bond scrambling in the course of digestion. The sample was
diluted with water to a final concentration of 1 µM. A portion of the final diluted solution
(50 µL) was submitted to trypsin digestion (protein/trypsin = 50/1, w/w) at 37 °C for 4 h.
The solution was then analyzed by LC-MS/MS whereby 5 µL of digestion solution was
consumed for each experiment.

Reversed-phase capillary LC separations were

performed with an Eksigent NanoLC-1D pump (Eksigent Technologies, Inc. Livermore,
CA). The reversed-phase capillary column (0.075 mm × 150 mm) was packed in-house
by using a PicoFritTM tip (New Objective, Inc., Woburn, MA) with C18 particles (Magic,
5 μm, 120 Å, Michrom Bioresources, Inc., Auburn, CA). The mobile phase consisted of
water, with 0.1% formic acid (A) and acetonitrile with 0.1% formic acid (B).
Immediately after sample loading, the mobile phase was held at 98% A for 12 min. A
linear gradient was performed by using 2% to 60% solvent B over 60 min, then to 80%
solvent B over 10 min at 260 nL/min followed by a 12 min re-equilibration step by 100%
solvent A. The flow was directed by PicoView Nanospray Source (PV550, New
Objective, Inc., Woburn, MA) to the LTQ Orbitrap (Thermo Fisher Scientific, Inc., San
Jose, CA). The spray voltage was 1.8-2.2 kV, and the capillary voltage was 27 V. The
LTQ Orbitrap was operated in standard data-dependent MS/MS acquisition mode
controlled by its Xcalibur 2.0.7 software, in which a full mass spectral scan was followed
by 6 product-ion (MS/MS) scans. The mass spectra of the peptides were acquired at high
mass resolving power (60,000 for ions of m/z 400) with the FT analyzer over the range of
m/z 350-2000. The six most abundant precursor ions were dynamically selected in the
order of highest to lowest intensity (minimal intensity of 1000 counts) and subjected to
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collision-induced dissociation (CID).

Precursor activation was performed with an

isolation width of 2 Da and activation time 30 ms. The normalized collision energy was
35% of the maximum available. The automatic gain control target value was regulated at
1 x 106 for FT and 3 x 104 for the ion trap with a maximum injection time of 1000 ms for
FT and 200 ms for the ion trap. The instrument was externally calibrated by using a
standard calibration mixture of caffeine, the peptide MRFA, and Ultramark 1621
(Thermo Fisher Scientific, Inc., San Jose, CA). To identify covalent modifications LCMS/MS data were searched with Mascot 2.2 (Matrix Science, London, UK) against the
NCBI database or MassMatix, an in-house search engine developed by Xu et al. (70-72).
Parameters used in Mascot were: enzyme, trypsin; maximum missed cleavage, 3; peptide
mass tolerance, 10 ppm with one C 13 peak; peptide charge, +1 to +3; product mass
tolerance, 0.6 Da; instrument type, default (searching for all types of b and y ions). To
locate disulfide bonds, LC-MS/MS data were searched with MassMatrix with the
parameter settings as follows: enzyme, trypsin; maximum missed cleavage, 3; variable
number of modifications by NEM on cysteines; precursor ion tolerance, 10 ppm; product
ion tolerance, 0.8 Da; max # PTM per peptide, 2; minimum peptide length, 4 amino
acids; maximum peptide length, 4 amino acids; min pp score, 5.0; min pptag score 1.3;
max # match per peptide, 3; max # combination per match, 3; fragmentation method,
CID; C13 isotope ions, 1; crosslink, disulfide; crosslink mode, exploratory; crosslink
sites cleavability, not applicatble; max # crosslinks per peptide, 2.

Results
The Kinetics of HDX for Ape'40 in the Presence and Absence of E3330 Are Nearly
Identical
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On the basis of a previous SPR study, we presume there is a strong binding
interaction between hApe1 and E3330 (binding constant of 1.6 nM) (38). We, therefore,
conducted HDX kinetics experiments with the Ape'40 concentration at 2.5 µM, as a
preliminary experiment prior to using PLIMSTEX (53-56) to verify the high affinity. For
PLIMSTEX to be applicable, there must be a difference in the HDX of the protein with
and without the ligand. We did not observe, however, any detectable difference in the
HDX kinetics for Ape'40 with and without the ligand over a range of protein
concentrations from 0.5 to 20 µM (Figure 5.3). With our custom kinetics model executed
in Mathcad, we assumed there are three types of exchanging amide protons: fast,
intermediate, and slow, and we used the kinetic model to determine the rate constants and
the number of amides in each category. The outcome was:
- k1 (fast exchange) = 5 min-1
- k2 (intermediate exchange) = 0.16 min-1
- k3 (slow exchange) = 0.008 min-1.
Based on the model, we were able to assign the number of amide protons of each
type. In 90% D2O, the numbers of fast, intermediate and slow exchanging amide protons
are 78 ± 2, 25 ± 4, and 43 ± 1 for Ape'40 in the absence of E3330 and 81 ± 3, 21 ± 2,
and 42 ± 1 for the protein in the presence of E3330. There is clearly no significant
difference between the extents of HDX for Ape'40 with and without E3330.
The results can have three explanations: first, the ligand doesn’t bind to the
protein under the conditions of the experiment. Second, there is binding of the ligand,
but it produces no significant change in the protein’s conformation (in particular, in the
amide backbone). Third, upon ligand binding, some regions of the protein become
protected while other regions become compensatorily deprotected, which fortuitously
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cancels any global effect. Although the second and third explanations seem improbable,
we sought other MS data to confirm or deny the first explanation.
ESI and nESI-MS Show No Strong Evidence of Ape'40/E3330 Complex
To test whether there is binding between Ape'40 and E3330 in the micromolar
and lower range of protein concentrations, we conducted ESI-MS with 50% ACN with
0.3% FA and nESI-MS with aqueous solution to monitor directly the complex formation.
Although this experiment is subject to giving false-negative results, we felt that if the
complex had such high affinity, it could be successfully introduced into the gas phase by
ESI.
We chose to begin this experiment with a “control” ligand quinone, compound 851 (see 8-51 structure) that is likely to react with solvent-accessible Cys residues.
Indeed, we observed evidence for an interaction between Ape'40 and the 8-51 quinone,
an analog of E3330, under regular ESI condition with water/acetonitrile/FA as the spray
solvent. A mass increase in the “decharged” protein signal of 274 Da indicates the
addition of one 8-51 molecule, associated with reduction to its hydroquinone form
(Figure 5.4).
To locate the sites of modification, we submitted the complex to trypsin digestion
and analyzed the peptide mixture by MS/MS. We were unable to detect any 8-51modified peptides, however. This suggests that those 8-51 molecules that added to the
protein giving detectable complexes in the mass spectrum of the intact protein underwent
an elimination reaction, restoring the modified cysteines to free thiols.

Thus, the

interaction was reversible, which would also be expected of the interaction with E3330.
Although we could not locate the modification sites by digestion and LC/MS/MS,
we can reason to their locations by a study of three Ape'40 mutants. ESI-MS of the
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mutants showed that the proteins added one 8-51 for C99A and C138A and no 8-51 for
C99/138A. These results are strong evidence that 8-51 specifically modifies C99 and
C138. Together with the evidence that the addition of 8-51 results in a mass increase of
274 Da suggested that 8-51 reacts with C99 and C138 via a Michael addition followed by
a reduction to its hydroquinone form. Unlike its analog 8-51, E3330 was only found to
form adducts with Ape'40 under certain ESI conditions (Figure 5.5). Considering the
distribution of adducts with different stoichiometries, we interpret the results as
indicators of non-specific interactions.
A typical ESI solvent consisting of water/acetonitrile/FA typically denatures
proteins and/or their complexes, so the inability to detect a complex sprayed from such a
solvent may be misleading about the formation of a complex in aqueous solution. An
alternative is nESI-MS with aqueous solution at near neutral pH; this approach is
becoming common for the detection of intact complexes in solution (73-75). Use of
nanoflow consumes less amount of sample and has gentler ESI conditions, including low
capillary voltage and no sheath gas, which are beneficial to maintain solution-state
complexes. Meanwhile, the high concentration of ammonium acetate is helpful for
increasing the signal-to-noise and resolving the charge states. Therefore, we used 1 M
ammonium acetate at pH 7.5 as ESI solvent in accord with the successful approach
reported by Robinson and her coworkers (73). Under these conditions, a small amount of
protein/E3330 adducts in the spectra can be admitted to the gas phase (Figure 5.6).
Sometimes, more than one adduct is seen as the ESI experiment (Figure 5.4), but the
results are not reproducible. We interpret the results as indicators of non-specific
interactions as well. The peaks representing the charge-states distribution of the protein
and of the protein/ligand complexes were shifted to higher m/z. This shift could be
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caused by a small change in protein conformation, allowing fewer charging events or by
insulation of the protein by the surrounding ligands, leading to fewer charges on the
protein or on the resultant protein/ligand complexes.
NEM Mapping Suggests a Locally Unfolded Conformer in Equilibrium with the Folded
Form
NEM specifically reacts with solvent-accessible cysteines in a protein via a
Michael addition. In the presence of NEM, Ape'40 only adds two NEMs as is indicated
by a mass shift of 250 Da (Figure 5.7 left panel). The reaction was complete, consistent
with the observation that all the protein was converted to its “+ 2 NEM” adduct after
incubation with NEM ([protein] = 100 µM; [NEM] = 500 µM) in approximately 10 min
at RT. Further LC-MS/MS analysis of trypsin-digested Ape'40/NEM complex
confirmed that NEM covalently modified the two cysteines (C99, C138) that X-ray
crystallography identifies as solvent-accessible (Figure 5.8) (28-31).
Interestingly, a new adduct appears when ApeΔ40 interacts with E3330 in the
presence of NEM. That adduct is produced in a reaction whereby all seven cysteines
became labeled with NEM. Although the reaction is slow, the yield of the adduct
increases slowly with time such that after 6 h, the product yield is approximately 25%
(Figure 5.7 right panel). Trypsin digestion coupled with LC-MS/MS analysis
conclusively indicates that protein is modified on the five remaining cysteines, which
were originally solvent-inaccessible, and not on other reactive amino-acid residues.
We asked whether the “+ 7 NEM” adduct was the result of E3330 denaturing the
protein. When we incubated ApeΔ40 (100 µM) and E3330 (500 µM) for 24 h at RT and
then added NEM to give a protein:NEM = 1:5 (mol/mol) and allowed any reaction to
occur for 0.5 h, we found addition of only two NEMs, not seven. If E3330 were acting as
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a denaturant, we would expect that all seven Cys residues would be modified. Therefore,
we propose that the “+ 7 NEM” adduct arises in a slow reaction of a locally unfolded
form whereby the “+ 2 NEM” state, which still has the native conformation, undergoes a
small extent of unfolding that is ultimately trapped by reaction with NEM (Scheme 5.1).
To elucidate more completely this interesting reaction, we conducted a kinetics
study to follow the “+ 2 NEM” state in its conversion to the “+ 7 NEM” state. Aliquots
were taken from a solution containing ApeΔ40/E3330/NEM (ratio = 100 µM:500 µM:
500 µM) as a function of time, quenched by adding DTT, and infused into a mass
spectrometer to monitor the relative abundances of the adducts. Data were fitted by
Mathcad to reveal that the rate constant for the rate-determining step in the reaction of
Ape'40 with NEM is 1.0 min-1 M-1, which is approximately 2000 times smaller than that
for reaction with a solvent-accessible Cys (Figure 5.9).
The Kinetics Are in Accord with a Locally Unfolded Form
The reactions of ApeΔ40, E3330, and NEM are described by a system of
equations (Scheme 5.1) that was worked by D. Rempel in the Gross group. The first
equation represents the heart of the unfolding processes: namely a binding equilibrium
with E3330 and a reaction with an interior cysteine of the ApeΔ40 molecule to give “+ 3
NEM”. The second and third equations show the sequential NEM reactions with the four
remaining interior cysteine sites.

These NEM products are assumed to remain in

equilibrium with E3330 as indicated by the fourth through eighth equations. The reaction
of solvent-exposed sites is represented by the ninth and tenth equations. Two exposed
cysteines react quickly with NEM as described by kNEM for a single site. Other exposed
sites on the ApeΔ40 react slowly to add effectively one NEM with rate constant, kslowNEM.
Because the sites are on the solvent-exposed surface, these reactions are postulated to
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proceed independently of each other and of the other processes involving the ApeΔ40
molecule. The symbol ApeΔ40 in the ninth and tenth equations represents any species of
ApeΔ40 in any other equation.
The correlated reaction of NEM with the five interior cysteines, as indicated by
the absence of the “+ 4 NEM”, “+ 5 NEM”, and “+ 6 NEM” adducts in the mass spectra
at all reaction times, indicates that the rate with which the unfolded ApeΔ40/E3330
complex refolds is low compared to the rate that the temporarily exposed cystine reacts
with NEM with an assumed rate constant of kNEM, and, as a consequence, that essentially
all of unfolded ApeΔ40/E3330 is represented by “+ 7 NEM” or “+ 8 NEM” adducts as
the unfolded ApeΔ40/E3330 is formed. A rate-limiting forward step in the first equation
is indicated by the long time scale (many hours) for the formation of the “+ 7 NEM” or
“+ 8 NEM” adducts of ApeΔ40 in the presence of E3330. This forward step may be due
to a unimolecular conformational change (from ApeΔ40 to ApeΔ40’ in the first equation),
governed by k’U, that allows E3330 to bind. As a unimolecular forward rate-limiting
step, the forward flux at this step should not be a function of the concentration of E3330.
An ApeΔ40/NEM mixture titrated with E3330 and observed at a fixed reaction time
shows that the “+ 7 NEM” adduct unambiguously increases with the E3330
concentration, thus, ruling out this possibility as the rate-limiting step. A rate-limiting
forward step could be possibly due to the rate (k*U) at which the E3330 bound ApeΔ40
(ApeΔ40’E3330) opens up (ApeΔ40*E3330) to expose one or more interior cystines to
react with NEM. In this possibility, a steady state for the ApeΔ40/E3330 binding is
established.

As the E3330 concentration is increased, the concentration of

ApeΔ40’E3330 reaches a maximum when all of Ape becomes bound.

The flux to

ApeΔ40*E3330 and, because of the high reactivity of NEM with the now exposed
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cysteines, the flux to the “+7 NEM” Ape adduct should show evidence of an asymptotic
maximum as E3330 is increased in an ApeΔ40/NEM mixture titrated with E3330. An
ApeΔ40-NEM mixture titrated with E3330 and observed at a fixed reaction time shows
that the “+7 NEM adduct increased with no trend to lower slope, which would suggest
the possibility of an asymptotic limit. This second possibility, thus, is ruled out. One is
left with binding rate between ApeΔ40 and E3330 (kON) as the rate limiting step. The
first equation is replaced by the eleventh equation for the system of equations that
describes the observable behavior of ApeΔ40. A key feature of this reaction is that it goes
to completion without any detectable intermediate adducts (e.g, those adducted to four,
five, or six NEMs).
Reaction with Mutant ApeΔ40 Indicates that C65 Is Not the Essential Cys
Others suggested that C65 is the essential residue for the redox function of
hApe1, and, therefore, it may be the preferred binding site of E3330 (24). Our results
indicate that ApeΔ40C65A also undergoes the same local unfolding that is stabilized by
E3330 and that reactions with NEM serve as a reporter for this process. Now, however,
the NEM product is “ApeΔ40C65A + 6NEM” (Figure 5.10). Therefore, C65 is not the
essential binding site for E3330 that stabilizes the local unfolding event.
Production of a “+ 3 NEM” Adduct Does Not Involve Cys
LC-MS/MS results of ApeΔ40/NEM after 6 h incubation show a small amount of
“+ 3 NEM” (Figure 5.6); this product comes from the NEM reaction with other, non Cys
solvent-accessible sites (e.g., K, H, and the –NH2 at the terminus) and is promoted by
excess NEM and long times (76). Although the general pKa values of K, H and the
terminal NH2 are higher than that of Cys, the immediate environment around these
residues may be favorable for the Michael addition. Therefore, we conclude that the “+ 3
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NEM” adduct arises from the same stable, folded conformer of the protein that gives rise
to the “+ 2 NEM” adduct (more evidence for this proposal is in the next section). We
propose that the “+ 3 NEM” adduct is a “dead end”, and is not an intermediate in forming
the “+ 7 NEM” species.
The Extent of HDX Is Different for the “ApeΔ40 + 2 NEM” and “ApeΔ40 + 7 NEM”
Our hypothesis at this point is that E3330 interacts with a locally unfolded form
of hApe1 to stabilize it. The reaction to give ultimately the “+ 7 NEM” adduct intercepts
this state and preserves it in a more opened form. If this hypothesis is correct, then we
should be able to see differences in the extent of HDX for the “+ 7 NEM” adduct in
comparison with the “+2 NEM” adduct. Furthermore, if the “+ 3 NEM” adduct is a
“deadend” as proposed above, its extent of HDX should match that of the “+2 NEM”
adduct. Indeed, the “+ 2 NEM” adduct exchanges 144 amide hydrogens whereas for the
“+ 7 NEM” adduct, the corresponding number of exchanges is 188 (Figure 5.11). We
used a kinetic model, reported earlier (77) to fit the data and “bin” the exchanging amides
into the number of fast, intermediate, and slow. For “ApeΔ40 + 2 NEM” adduct, the
number of exchanging amide H’s are 81± 1, 20 ± 4, 43 ± 2; for the “Ape Δ40 + 3 NEM”
adduct, the number of amides are 81 ± 2, 19 ± 2, 41 ± 1, whereas for the “Ape Δ40 + 7
NEM” protein, the numbers are 136 ± 3, 14 ± 1, 38 ± 4. Clearly, the number of fast
exchanging adducts has increased substantially for the unfolded conformer that becomes
“locked-in” as a result of the reaction with NEM. “ApeΔ40 + 7 NEM” has 40 more
exchanging amide H’s than ApeΔ40/“ApeΔ40 + 2 NEM”/ “ApeΔ40 + 3 NEM”, which is
in agreement with the existence of a locally unfolded form.
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Considering that there are 318 total amide hydrogens in the protein, we see that
only 59% underwent exchange even for the protein modified with seven NEMs,
indicating that “+ 7 NEM” form is a locally unfolded form and not a denatured one.
The HDX results for ApeΔ40, “ApeΔ40 + 2 NEM” and “ApeΔ40 + 3 NEM”
proteins are similar (compare Figures 5.3 and 5.11), confirming that these three species
have the same conformation and that additions of NEM to the solvent accessible Cys and
to other reactive sidechains do not change the conformation of ApeΔ40.
The E3330 Interaction with ApeΔ40 Also Allows Disulfide Bond Formation
One hypothesized redox mechanism of hApe1 is thiol/disulfide exchange. That is,
the Cys residues that are involved in redox activity become oxidized to disulfides as
hApe1 reduces transcription factors. It is possible that E3330 inhibits the redox activity
of hApe1 by stabilizing the locally unfolded form, allowing it to be oxidized prematurely,
and making it unavailable as a reducing agent for other proteins. When we treated
ApeΔ40 (10 µM) with E3330 (50 µM) for 1 h at 37 ºC in the absence of NEM, digested
the mixture with trypsin in the presence of NEM (to prevent disulfide bond scrambling),
and analyzed the digest by LC-MS/MS, we found that E3330 induced disulfide bond
formation among the various Cys especially in the redox domain (C65, C93, and C99).
The relative abundance of disulfide bonds in the ApeΔ40 redox domain C65-C93, C6593 and C93-C99 increased owing to the interaction with E3330 from 0.16, 0.01, and 0.04
to 8.2, 1.6, and 5.8%, respectively (Figure 5.12). MS2 spectra identifying the disulfide
linkages are show in Figures 5.13, 5.14, 5.15, 5.16, and 5.17. As proved by NEM
mapping experiments that show “+ 2 NEM” going to “+ 7 NEM”, E3330 interacts with
and stabilizes the locally unfolded form of ApeΔ40, which then becomes oxidized by
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forming disulfide bonds. Thus, this locally unfolded form of ApeΔ40 may be responsible
for the redox activity of the protein.
Comparison with Full-length Ape (FL-Ape)
To test if FL-Ape undergoes the same local unfolding process, we tested the FLApe /E3330/NEM sample after 12 h incubation by ESI-MS, using an identical approach
as that used for ApeΔ40. We also observed the transition from “+2 NEM” to “+ 7 NEM”
adduct (Figure 5.18) without any detectable intermediates, suggesting FL-Ape undergoes
the same local unfolding as ApeΔ40, and that form is stabilized by the interaction with
E3330.

Discussion
Until now, the role of hApe1 in the reduction of transcription factors has
remained unclear. It is generally agreed that one or more of the three Cys in the redox
domain are involved in the redox activity (67, 78), but there are no results that locate the
redox-active cysteines.

In cell-based experiments, the hApe1 mutant C65A (C65

replaced with A) shows nearly no redox activity, C93A retains approximately 50%
activity, and C99A retains approximately 80% activity (66). These results are in accord
with a conclusion that not only is C65 essential for redox activity but also C93 and C99
are involved.
We suggest that another way to elucidate the redox mechanism of hApe1 is
through a study of the interaction of hApe1 and its inhibitor E3330 by using various
forms of chemical footprinting with analysis by mass spectrometry. Those residues that
become solvent-accessible and interact with E3330 may be those that are redox-active in
the reduced form of hApe1. The only study that bears on this prospect is one that
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afforded a Kd of 1.6 nM for the binding of hApe1 and E3330, as determined by SPR (38),
indicating strong and specific binding between hApe1 and E3330. We find no evidence
for this strong interaction. Ape'40, a truncated form of hApe1 with the full redox and
DNA repair activities, was used for our study. Our HDX kinetics results are in accord
with no significant difference between ApeΔ40 without and with E3330 at protein
concentrations in the range of 0.5-20 µM. It seems highly unlikely that an interaction as
strong as that with a Kd = 1.6 nM would cause no changes in the extent of H bonding and
in the conformation of ApeΔ40. One explanation of the SPR results is that the E3330 is
reacting with the (possibly denatured) protein to give a very small koff.
Efforts to detect the complex directly by ESI also provided no convincing
evidence for its existence, either by ESI-MS with 50% ACN with 0.1% FA or by nESIMS of aqueous solutions at neutral pH. An abundant complex, however, does form when
ApeΔ40 interacts with 8-51, another quinone and an analog of E3330. It is likely that the
–OMe leaving group of 8-51 makes it a more labile reactant than E3330 for the solventaccessible Cys residues. Nevertheless, the reaction shows conclusively that covalent bond
formation with a quinone ligand can be detected by ESI-MS. Thus, we conclude that
E3330 does not interact strongly or react irreversibly with ApeΔ40 via a Michael
addition or any other reaction.

Nevertheless, E3330 does specifically interact with

hApe1 via a process that may be general for other proteins with solvent-accessible
cysteines. What are the details of this interaction between ApeΔ40 and E3330?
The NEM mapping experiments surprisingly show formation of a species
“ApeΔ40 + 7 NEM” in the presence of E3330. We propose that the ApeΔ40 form that
becomes modified with seven NEMs is locally unfolded. Therefore, ApeΔ40 must exist
in at least two equilibrating conformers (folded and locally unfolded) in solution. The
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locally unfolded form, in the absence of E3330, is too small a fraction to be detectable by
MS methods. In the presence of E3330, however, this locally unfolded form is stabilized
by E3330, its relative concentration increased, and it is ultimately trapped in a slow
reaction with NEM. The first adduct of a normally inaccessible Cys, the “+ 3 NEM” form
(3 Cys modified), is sufficiently long-lived and its conformation sufficiently open that the
remaining four Cys residues now can react rapidly with NEM in a cascade effect
(Scheme 5.1). The outcome is an irreversible uptake of five additional NEMs by Cys
residues that are inaccessible in the folded and stable conformation of the protein.
The effects of E3330 are only apparent in the presence of NEM. If NEM were
added to ApeΔ40 that was equilibrated for an equal time with E3330, no uptake of seven
NEMs can be seen, consistent with the fact that addition of NEM is a slow reaction
owing to the low concentration of the locally unfolded form, whereas the reaction is fast
for solvent-accessible Cys residues. The “+ 7 NEM” species is viewed as a trapped
unfolded form that cannot convert back to its folded state owing to the Cys modifications.
This locally unfolded form is not detectable by HDX because its concentration is too
small. We propose, however, that HDX of the “+ 7 NEM” is a measure of the locally
unfolded form. The locally unfolded conformer that interacts with and is stabilized by
E3330 may be the sought-after form that functions as the redox factor.
More confirmation of this picture comes from the measurement of extent of
disulfide bond formation in the presence of E3330. Indeed, disulfide bond formation
among the cysteines in the redox domain is enhanced in the presence of E3330, providing
evidence that the interaction with E3330 is relevant to the redox activity of hApe1. We
interpret the results to indicate that, in the locally unfolded form, the cysteines in the
redox domain are sufficiently close to form disulfide bonds. Although other disulfide
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bonds (C65-138, C93-138) also form, their role in the inhibition activity of E3330 is not
yet explained. It is also not clear whether E3330 initiates the disulfide bond formation or
whether two thiols simply react with each other spontaneously in the locally unfolded
form.

Conclusions
ApeΔ40 exists in solution as an equilibrium between a major folded form and a
minor locally unfolded form. The locally unfolded form with at least one formerly
solvent-inaccessible cysteine exposed to solvent is proposed to be the one that interacts
with E3330. This form can be trapped by NEM reactions and can form disulfide bonds
among the various cysteines in the redox domain of ApeΔ40. The FL-Ape underwent the
same unfolding process upon interacting with E3330 in the presence of E3330, indicating
the same equilibrium between a major folded form and a minor locally unfolded form
exists for hApe1. Therefore, we propose that the locally unfolded form is responsible for
the redox activity of hApe1 via a thiol/disulfide exchange mechanism. A possible
pathway in this mechanism is that C65 acts as a nucleophile to attack a disulfide in the
target protein, producing a transient mixed disulfide intermediate. The intermediate is
then reduced by C93 and C99 producing a dithiol in the target protein and a disulfide
bond in hApe1.
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C138
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C208

C99
C296
C65

C310

Figure 5.1. X-ray crystal structure (PDB: 1BIX) of hApe1 with seven cysteines shown
as sticks (red). C99 and C138 are surface accessible, whereas C65, C93, C208, C296,
and C310 are buried. C65, C93, and C99 are located in redox domain. C65 is thought to
be essential in the redox chemistry of the protein.
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Figure 5.2. Amino acid sequence of the ApeΔ40 (cysteine residues are underscored).
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ApeΔ40 without E3330
ApeΔ40 with E3330

Figure 5.3. HDX kinetics of ApeΔ40 alone and in the presence of E3330. The curves
were fitted with a custom program operating in MathCAD. It used the D uptakes of
ApeΔ40 after 1 h incubation without and with E3330. The protein concentration was 12.5
µM, and for the experiment in the presence of E3330, the [protein]/[E3330] was 1/10.
The samples were incubated in 10 mM HEPES with 150 mM KCl at 25 ºC for 1 h. HDX
was done in a 90% D2O medium (pH 7.5) with 10 mM HEPES and 150 mM KCl at 25 ºC.
The HDX reaction was quenched by adding sufficient 1.0 M cold HCl to give a pH of 2.5.
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Figure 5.4. ESI mass spectra of ApeΔ40 (A) and its mutants C99A (B), C138A (C),
C99/138A (D) after interaction with compound 8-51. Mass spectra were collected on a
Bruker MaXis UHR-TOF instrument and deconvolution was done with MaxEnt1
algorithm.
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Figure 5.5. ESImass spectrum of ApeΔ40 and E3330 with 50% ACN with 0.1% FA at
10 µL/min. Sample was incubated in 100 mM ammonium bicarbonate at pH 7.5 for 4 h at
RT and before MS analysis: [protein] = 100 µM; [E3330] = 500 µM. The symbol *
denotes peaks for the water and salt adducts. Data were collected on a Waters Micromass
Q-TOF instrument, and deconvolution was done with MaxEnt1 algorithm provided with
that system. Instrument parameters were the same as described in the HDX experiments
except theflow rate was 10 µL/min, capillary voltage was 2.5 kV, and the collision
energy was 5 eV.
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Figure 5.6. NanoESI mass spectra of ApeΔ40 without (A) and with E3330 (B). Samples
were incubated in 1 M ammonium acetate at pH 7.5 for 4 h at RT and then directly
analyzed by nESI-MS ([protein] = 100 µM; [E3330] = 500 µM). Mass spectra were
collected on a Bruker MaXis UHR-TOF instrument.
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Figure 5.7. ESI mass spectra of ApeΔ40 after incubation without and with E3330 in the
presence of NEM for 30 min (left panel) and 6 h (right panel). Samples were incubated in
10 mM HEPES with 150 mM KCl at pH 7.5([protein] = 100 µM; [E3330] = [NEM] =
500 µM). The symbol * denotes peaks for the water adducts. Mass spectra were collected
on a Waters Micromass Q-TOF instrument and deconvolution was done with MaxEnt1
algorithm provided with that system.
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Figure 5.8. MS/MS spectra that show C99 and C138 were modified by NEM. Product
ions labeled in read contain the NEM modified cysteines C99 (A) and C138 (B). The
symbol ++ denotes doubly charged ions.
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Figure 5.9. Kinetics of Ape and NEM reaction in (A) Ape Δ40/NEM sample and (B)
ApeΔ40/E3330/NEM sample. Both samples were prepared in 10 mM HEPES at pH 7.5
at RT ([protein] = 100 µM; [E3330] = [NEM] = 500 µM). Aliquots were quenched with
DTT at various times. Mass spectra were collected on a Bruker MaXis UHR-TOF
instrument, and deconvolution was done with MaxEnt1 algorithm provided with that
system. The sums of intensities of different NEM adducts of ApeΔ40 were normalized to
1. Data were fitted with Mathcad. The value of kNEM was determined in a relatively
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straight forward one-parameter fit of the “+ 2 NEM” adduct kinetic curves. A value of
2100 min-1 M-1 was obtained when the relative sensitivity factor was fixed as a constant.
When gN was fixed at the more extreme value of 1/NEM, a better fit was obtained, and a
value for kNEM of 1500 min-1 M-1 was obtained. This variation is only 29% despite the
uncertainty of ESI sensitivity as a function of the number of adducted NEMs.
The “+ 7 NEM” kinetic curves where fit by allowing three parameters to vary. They are
listed with their solution values in the following equations.
kslowNEM = 0.741932547 min-1 M-1
kON = 1.010476359 min-1 M-1
gN = 0.6519354671
For this calculation, it was assumed that effect of the dissociation rate of the
ApeΔ40/E3330 complexis small.

This is consistent with the hypothesis that the

association is the rate limiting step so that the concentration ApeΔ40*E3330 remains
small because of the relatively rapid reaction with NEM.

The value of kOFF must

approach the value of kNEM in order for there to be an effect. The value of kNEM was fixed
at 1740 for the fit.
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Figure 5.10. ESI mass spectra of ApeΔ40 mutant C65A without and with incubation
with E3330 in the presence of NEM for 12 h. Samples were incubated in 10 mM HEPES
at pH 7.5([protein] = 100 µM; [E3330] = [NEM] = 500 µM). The symbol * denotes water
adducts. Mass spectra were collected on a Waters Micromass Q-TOF instrument and
deconvolution was done with MaxEnt1 algorithm that was part of that system.

180
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ApeΔ40+3NEM
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Figure 5.11. HDX kinetics results of “ApeΔ40 + 2 NEM”, “ApeΔ40 + 3 NEM” and
“ApeΔ40 + 7 NEM”. ApeΔ40/E3330/NEM sample was incubated in 10 mM HEPES
with 150mM KCl (pH 7.5) for 22 h at RT ([protein] = 100 µM; [E3330] = [NEM] = 500
µM). Reaction was quenched by adding DTT. HDX was conducted in a 93% D2O
medium with 10 mM HEPES (pH 7.5) and 150 mM KCl at 25 ºC and quenched by
adding sufficient 1 M cold HCl to give a pH of 2.5.

181

9

8.20

8

Control

Relative abundance (%)

7

E3330

5.75

6
5
4
3

2.61
1.61

2
1
0.16

0.01

0.04

0
C65-C93

C65-C99

C93-C99

0

0.31

C65-C138

0.01
C93-C138

Disulfide Bonds

Figure 5.12. Normalized percentages of disulfide linkages in the ApeΔ40 control and
ApeΔ40/E3330 samples. Samples were prepared by incubating the protein without
(control) and with E3330 in 10 mM HEPES at pH 7.5 for 1 h at 37 ºC ([protein] = 10 µM;
[E3330] = 50 µM). An excess of NEM (protein/NEM = 1/50, mol/mol) was immediately
added to quench the disulfide crosslinking reaction and prevent disulfide scrambling
during the subsequent digestion process. Data base searching was done with MassMatrix,
an algorithm with the ability to identify disulfide-linked and crosslinked peptides (70-72).
The amounts of peptides were estimated by dividing the peak areas in the LC
chromatogram of the disulfide-linked peptides by that of a “standard” peptide
“WDEAFR” in the sequence, which does not become modified during the sample
preparation and LC-MS/MS analysis process. The assumption for this method is that
there is no or little ionization discrimination between the “standard” peptide and the
didulfide linked peptides. No C65-C138 linkage was observed in the control sample. Bars
represent “mean ± standard derivation” taken from triplicate measurements.
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Figure 5.13. MS/MS spectrum that shows disulfide bond formation between C65 and
C93. Product ions generated from peptide A are labeled in read and those from peptide B
in green. The symbol ++ denotes doubly charged ions; the symbol +++ denotes triply
charged ions.
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Figure 5.14. MS/MS spectrum that shows disulfide bond formation between C65 and
C99. Product ions generated from peptide A are labeled in read and those from peptide B
in green. The symbol ++ denotes doubly charged ions; the symbol +++ denotes triply
charged ions.
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Figure 5.15. Product-ion spectrum (MS/MS) showing disulfide bond formation between
C93 and C99. Product ions generated from peptide A are labeled in read and those from
peptide B in green. The symbol ++ denotes doubly charged ions; the symbol +++ denotes
triply charged ions.
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Figure 5.16. MS/MS spectrum that shows disulfide bond formation between C65 and
C138. Product ions generated from peptide A are labeled in read and those from peptide
B in green. The symbol ++ denotes doubly charged ions; the symbol +++ denotes triply
charged ions.
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Figure 5.17. MS/MS spectrum that shows disulfide bond formation between C93 and
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Figure 5.18. ESI mass spectrum of FL-Ape with E3330 in the presence of NEM for 12 h.
Sample was incubated in 10 mM HEPES at pH 7.5([protein] = 100 µM; [E3330] =
[NEM] = 500 µM). Mass spectrum was collected on a Bruker MaXis UHR-TOF
instrument and deconvolution was done with MaxEnt1 algorithm.
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Scheme 5.1. Proposed system equations explaining the NEM labeling of ApeΔ40 in the
presence of E3330.
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